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ABSTRACT
SEROTYPE ASSOCIATION AND REGULATION OF THE HYALURONATE
LYASE GENE OF
STREPTOCOCCUS PYOGENES

Martha Stokes
Old Dominion University, 2007
Director: Dr. Wayne Hynes

S. pyogenes expresses many virulence factors, controlled by a complex
regulatory network. These include hyaluronate lyase, an enzyme that degrades
hyaluronic acid, a major component of the human extracellular matrix.
Paradoxically, hyaluronic acid is also the sole component of the bacterium’s
capsule, a primary defense against the host immune response. The hylA gene,
which encodes the enzyme, has been shown to take three structural forms: a fulllength gene, one containing a 3’ deletion and a gene that produces a prematurely
truncated protein. This work was intended to show that the structure of hylA is
associated with serotype, and therefore, disease pattern of S. pyogenes.
The structure of hylA was determined to have two regions where changes
that influence amino acids, and therefore protein structure, result in a loss of
enzymatic activity. The 3’ region contains the deletion and the premature stop
codon, and an area of the 5’ region contains a one-amino acid change that leads
to a loss of activity. Site-directed mutagenesis of the amino acid in the 5’ region
resulted in a restoration of activity in a truncated strain but not in a deleted strain,
suggesting a relationship between the 3’ and 5’ domains.
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Epidemiological studies of a number of strains showed that serotypes
containing the full-length hylA gene produce an active enzyme, while other
serotypes have one of the other two gene structures and do not produce an
active enzyme. Enzyme-producing serotypes of S. pyogenes correlate with noninvasive infection, whereas those serotypes causing more invasive and lifethreatening infections tend to be enzyme-negative.
Mutagenesis of proteins associated with other virulence factors in S.
pyogenes gene failed to identify the regulator of hylA expression. The mga gene,
the covR gene and other two-component response regulators were knocked out,
but none were shown to affect hylA expression. Further investigations will
explore other regulators controlling virulence factors and metabolic processes.
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1
INTRODUCTION
Streptococcus pyogenes and other streptococci. Streptococcus
pyogenes, or group A streptococcus (GAS) is a gram-positive bacterium capable
of causing a wide array of diseases, from self-limiting and uncomplicated
infections to severe and invasive and even fatal forms. It has had a long
evolutionary history with its Homo sapiens host, which is its only known natural
reservoir. As a result of this lengthy association, the bacterium has developed a
remarkable arsenal of adaptations, including numerous virulence factors, which
allow it to infect and survive in diverse host environments. Consequently, the list
of diseases caused by S. pyogenes is large and strikingly varied, making this
species the most pathogenic of the Streptococcus genus (23). Members of the
genus Streptococcus are hemolytic, nonmotile, non spore-forming, catalase
negative cocci. The cells typically form pairs or chains and are initially classified
on the basis of the colony morphology. Streptococci are a heterogeneous group
of bacteria, are often a component of the normal microflora of animals including
humans, and many are of great medical significance. Nomenclature of
streptococci has traditionally been based on serological identification of cell wall
components that elicit antibody response; in addition to S. pyogenes, other
medically important streptococci are S. pneumoniae, S. agalactiae and the group
D enterococcal species, which in 1984 were placed into a separate genus,
Enterococcus (9).

The journal model for this dissertation is Infection and Immunity
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The cell wall of streptococci is composed of peptidoglycan-containing
repeating units of A/-acetylglucosamine and A/-acetylmuranic acid. Hemolytic
streptococci are differentiated into groups based on the antigenic properties of
cell surface carbohydrates. The group A streptococci are distinguished from
other groups by a carbohydrate composed of /V-acetylglucosamine linked to a
rhamnose polymer backbone (18). Pioneered by Dr. Rebecca Lancefield in
1920, classic characterization of GAS used methods of typing based on the
antigenic properties of the cell wall-associated M and T proteins. The T proteins,
of which there are approximately 30 types, are identified in a slide agglutination
test using T antisera. The M protein is typed using M type-specific antisera in a
precipitin reaction; there have been approximately 90 M types characterized
using this method. Further, a type-specific cell surface enzyme known as serum
opacity factor, which causes mammalian serum to become opaque, can be
identified using an anti-OF inhibition test. These classic serological methods,
however, are very labor-intensive and use antisera which are not commercially
available and difficult to maintain (51). The methods continued to be used until
the late 1980’s, even though there were numerous “provisional” M-type strains
identified that could not be classified using the Lancefield scheme; either they did
not fit specific criteria or could not be verified by a second lab.
In 1997 a more rapid typing method was developed, based on the
sequence of the 5’ hypervariable portion of the emm gene that encodes the M
protein. This methodology resulted in the identification and inclusion of the
provisional M-type strains as well as the addition of newly-identified types. In
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order to facilitate identification of GAS strains by this method, the Centers for
Disease Control has established an emm sequence database, and maintains a
website that can be used for emm typing (24). At the current time, over 100
genotypes of GAS have been identified using the emm-genotyping method.

Diseases caused by S. pyogenes. As well as pharyngitis, or “strep
throat”, S. pyogenes can cause a large and varied number of illnesses.
Infections of the mucosa and skin include impetigo, erysipelas, vaginitis and
post-partum infection, while deeper infection can result in bacteraemia,
necrotizing fasciitis, cellulitis, myositis, puerperal sepsis, pericarditis, meningitis,
streptococcal pneumonia and septic arthritis. Infection with S. pyogenes can also
lead to the toxin-mediated diseases scarletina and toxic shock-like syndrome.
Further, immunologically-mediated post-infection sequelae such as rheumatic
fever, glomerulonephritis and reactive arthritis can also occur. This capability to
cause such diverse infections is due, in part, to the multiple virulence factors that
S. pyogenes possesses. A virulence factor is an agent produced by the
bacterium that allows the organism to become established in its host or to
maintain the disease state once infection has developed (27). Before the
introduction of antimicrobials at the end of World War II, serious infection with S.
pyogenes was quite common in the United States, and infection was responsible
for up to half the deaths from post-partum infection (childbed fever). S. pyogenes
was also a major cause of death in burn patients in the US (21). But fortunately,
S. pyogenes was, and still remains exquisitely sensitive to penicillin (18). The
broad use of antibiotics led to a drastic reduction in severe infections, so much so
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that by the 1970s it was hoped that the pathogen would be effectively eradicated
in developed nations (21). However, this has not proven to be the case. Around
the mid 1980s, there was a resurgence of diseases caused by S. pyogenes, with
a shift in the epidemiology towards more severe and invasive clinical illness. The
emergence of streptococcal toxic shock syndrome also occurred at this time and
studies indicated an increase in the numbers of isolates of M-types 1 and 3,
correlating these M-types with the more invasive diseases (53). During this
same time period, an outbreak of acute rheumatic fever (ARF), which had been
on the decline for decades, occurred in the western part of the United States.
The clinical isolates were associated with M-genotype 18. ARF and rheumatic
heart disease, which can occur subsequent to streptococcal infection, have
always been a problem in developing nations. But, the resurgence in the United
States, coupled with the increase in other S. pyogenes-mediated illnesses, led to
increased study of strain-associated epidemiology and virulence factors that
could contribute to the pathogenesis of S. pyogenes (64).

Serological association w ith disease pattern. The human host
provides a variety of environments to which S. pyogenes has adapted, and in
order to infect and cause disease, the bacterium has developed complex
virulence mechanisms to evade both the innate and adaptive immune systems.
Because there are such differences in the types of diseases and sequelae
caused, and because there are so many different serotypes of S. pyogenes, a
tremendous amount of epidemiological research has been conducted to
determine any association between M-type and disease. The two sites of initial
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colonization are the superficial layers of the epidermis and the mucosal
epithelium of the upper respiratory tract, and there has long been a concept of
distinct throat and skin serotypes of S. pyogenes (18). Additionally, serotypes of
GAS have been more broadly categorized into either Class I or Class II based on
epitopes present within a conserved region in the M protein. With the post
infection sequelae, different S. pyogenes M type classes have been associated
with rheumatogenicity or nephritogenicity (14).
The non-random association of M protein serotypes with particular clinical
syndromes has been recognized for decades with M-types 1, 3 and 18 being of
particular medical interest. M1 serotypes are the most common cause of
invasive disease and most often associated with epidemics. One clonal strain in
particular, M1T1, has been the most frequently isolated serotype from both
invasive and noninvasive S. pyogenes infections worldwide (7). M3 serotypes
are also linked to severe invasive disease and have been associated with
streptococcal toxic shock syndrome. The link of M18 serotypes to outbreaks of
ARF has been repeatedly established (8). Specific M-types have been
associated with post streptococcal glomerulonephritis, (29), and in addition to
M18 serotypes, M-types 5, 6, 19 and 24 have likewise been linked to ARF. So
patterns do exist, not only in a preferential distribution of M genotypes in skin or
throat infection sites but also in the distribution of genotypes among cases
displaying different clinical manifestations of invasive disease (67).
The apparent association between disease and M-type suggests that
different M-types possess unique virulence gene profiles that give rise to the
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differences in disease pattern (46). While there have been numerous studies
tying the two together, exceptions have always been found, particularly between
different geographic locations, that preclude the establishment of an iron-clad
association between any one M-type and any specific disease characteristic.
Recent epidemiological studies have employed a combination of microarray
analysis and machine learning-based computer algorithms, designed to study
large and complex datasets, rather than traditional statistical methods. In studies
of 60 virulence genes involved in adherence, immune evasion and modulation,
transmission and cellular disruption, only three genes could be marginally tied to
the more invasive strains of S. pyogenes. One gene, spa, encodes a fibronectin
binding protein while the other two, ssa and mfA, encode proteins that act as
superantigens, proteins that over-stimulate the host immune response to
infection (45).
Most gene profiling studies carried out to date have been limited to one M
type, to previously identified virulence factors, or have utilized the completely
sequenced genomes that are currently available, most of which are strains from
North America. The relationship between the genetic profiles of different M types
of S. pyogenes and their clinical manifestations may lie in unidentified genes,
differences in gene regulation between M types, or some combination of a variety
of factors (68). This current lack of understanding of the correlation between
factors emphasizes the complexity of the relationship between the human host
and the bacterium and suggests allelic differences and host susceptibility are
potentially just as important as the virulence profile of the bacterial strain (45).
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The role of phage In bacterial virulence. Most species of pathogenic
bacteria exhibit much greater genetic variation than eukaryotic organisms.
Clinically important characteristics such as virulence and antimicrobial resistance
differ dramatically amongst bacterial species as well as strains (10).
Bacteriophages, the most populous organism on the planet, with around 1030
inhabitants, are viruses that infect only bacteria (52). Phages and phage-like
elements encode virulence factors in many pathogenic bacteria including S.
pyogenes, and are known to account for the majority of variation in strain genetic
content. This occurs not only by the introduction of new genetic material by the
infection by phage but also by phage-induced genomic rearrangements within
the bacterial chromosome, which can lead to further diversification (50).
Additionally, the phage genome itself may exhibit a high level of diversity, owing
to genetic mosaicism, the phenomenon by which tailed phages shuffle genetic
modules, likely increasing phage fitness and enhancing the dissemination of the
genes within those shuffled modules (7).
While the importance of the phage contribution to bacterial diversity and
pathogenesis is well known, the magnitude of phage-encoded diversity in S.
pyogenes is unmatched, accounting for an average of 56.2% of the unique gene
content seen between strains. Comparisons of the M1, M3 and M18 genomes
show that a majority of chromosomally encoded proteins share 90% or greater
amino acid sequence identity, yet the majority of phage-encoded proteins share
10% or less sequence identity (8). In another study comparing the same
genomes, it was found that only three genes were statistically overrepresented in
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more invasive strains. All three of these genes are carried on bacteriophages,
with two encoding superantigens which are known to magnify the host immune
response, leading to greater morbidity and mortality (45).
The reason why the contribution of bacteriophages to virulence in S.
pyogenes is so great is a matter of speculation, but it is clear the conversion from
nonpathogenic to pathogenic strains is frequently mediated by bacteriophage
infection (63). Two reasons why phage-determined variation has become so vital
to bacterial survival have been proposed. First, the variation gained by the
presence of phage may increase colonization rates or enhance fitness by
promoting temporal or geographic variation in disease frequency and severity.
Second, the addition of new phage-encoded virulence factors to the genome of a
GAS strain that is already associated with severe or invasive diseases could
create an unusually virulent sub-clone, such as the M3 strains that surfaced
beginning in the mid-1980s (8). Regardless of the reason, it is clear that the
phage-mediated acquisition of genes has been an evolutionary advantage to
GAS, driving the diversification of the genome and contributing to the survival
and virulence of the pathogen.

Virulence factors of S. pyogenes. The bacterium S. pyogenes
expresses a multitude of virulence factors which function in adherence, immune
system evasion, tissue destruction, spreading and cell toxicity (30), with some
performing multiple functions. The proteins, enzymes and polysaccharides that
are produced remain either cell-associated or are secreted from the bacterium.
The M protein, one of the most important virulence factors, in particular, plays
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many roles including immune response evasion, adherence, internalization and
invasion.
Attachment of the S. pyogenes bacteria to host epidermal or pharyngeal
cells is the most important first step in the colonization process and can involve
multiple adhesins (18). The M protein allows cells to bind keratinocytes in skin
infections as well as pharyngeal cells in throat infections (15). Other adhesins
produced by S. pyogenes include lipotechoic acid and fibronectin binding
proteins, which function in binding the bacterial cell to host oral epithelial cells,
and the hyaluronic acid capsule, which binds keratinocytes on the pharyngeal
mucosa and skin via their CD44 receptors (12). These organisms also produce at
least 9 other proteins that bind host factors including collagen, vitronectin and
galactose (18).
The M protein of S. pyogenes also functions in evasion of the host
immune response. Encoded by the emm gene, this dimeric, alpha helical coiledcoil fibril extends from the surface of the bacterial cell. By binding the human
plasma protein C4BP, an inhibitor of the classical complement pathway
activation, decreased complement deposition on the bacterial cell surface allows
the bacteria to resist phagocytosis (5). The M protein is also able to bind factor H
as well as fibrinogen and thus diminishes the alternative complement pathwaymediated binding of C3b to the bacterial cell, hampering recognition by
polymorpholeukocytes (13). The NH2-terminus portion of this protein is a
hypervariable region exhibiting the antigenic variation that is the basis for the
serological typing and emm-genotyping of S. pyogenes strains. This region is
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followed by a set of three repeat regions, A, B and C, an LPXTG motif common
to cell wall-anchored proteins and a hydrophobic domain, which is embedded in
the cell membrane (72).
Two other virulence factors designed to combat the host immune
response are C5a peptidase and the hyaluronic acid capsule. C5a peptidase is a
surface-associated endopeptidase that targets C5a, a chemotactic signal for all
host complement pathways (30). The hyaluronic acid capsule is a highmolecular-weight polysaccharide composed of repeating disaccharide units of Nacetylglucosamine and glucuronic acid. This creates a barrier around the cell,
allowing it to resist phagocytic killing. Additionally, there are a number of proteins
secreted by S. pyogenes which are able to bind fibronectin, and therefore
putatively function in adhesion and/or evasion of host immunity. This group
includes protein F, Sfbll, PrtF2, Fbp54, Pfbp, FbaA and FbaB (30).
A number of the extracellular products secreted by S. pyogenes play a
role in the destruction of tissue, facilitate the spread of bacteria deeper into host
tissues or have a cytotoxic effect on the host. Proteases, including SpeB, break
down proteins, which are then transported into the bacterial cell to be used as an
energy source (30). They likely play a role in tissue destruction as well. DNases,
hyaluronidases and streptokinase facilitate the liquefaction of pus and the
degradation of clots, allowing for the spread of bacteria through tissue planes
characteristic of necrotizing fasciitis and cellulitis (13). Streptolysins O and S are
hemolytic toxins that target macrophages, leukocytes and platelets in addition to
erythrocytes (30). In addition there are the streptococcal pyrogenic exototoxins.
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The Spe proteins are a family of superantigens that are potent immunostimulators and have been associated with streptococcal toxic shock syndrome.
These proteins interact non-specifically with host T cells and the MHC class II
molecules of antigen-presenting cells to costimulate an enormously increased
immune response. While conventionally-presented antigens normally interact
with one in every 104 T cells, superantigens are capable of interacting with as
many as 1 in 5 of resting T cells (38).
The preceding is only a partial list of virulence factors employed by S.
pyogenes as it infects its human host. As the function of proteins putatively
identified on the basis of homology to known virulence factors is elucidated, the
complete list will eventually be characterized. Individually, each factor plays a
role in the disease process that includes colonization, invasion, evasion of host
immunity, replication and ultimately, transmission to a new host. But viewed as a
whole, they represent a formidable virulence arsenal, as well as an important
component in the explanation for why S. pyogenes is such a successful
pathogen.

Hyaluronidases and the hyaluronate lyase of S. pyogenes. Many
pathogenic bacteria, including S. pyogenes, produce hyaluronidases, enzymes
that are capable of degrading hyaluronate, a major constituent of the extracellular
matrix found throughout the human body. Hyaluronate, or hyaluronic acid, is a
large linear polymer made up of alternating N-acetlyglucosamine and glucuronic
acid residues, which are linked by glycosidic bonds to form a highly viscous
polysaccharide. The enzymes that break down this substance generally
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classified as hylauonidases are divided into three classes, based on the
mechanism of cleavage of the substrate. Testicular hyaluronidase is an endo-Nacetyl-D-hexaminidase that degrades its substrate to leave a tetrasaccharide as
the end product. The hyaluronidase produced by leeches is a pendoglucuronidase that degrades the substrate to form octasaccharides (36).
Both of these enzymes use a hydrolysis mechanism to break down the
hyaluronic acid. The third group, employed predominantly by bacteria, uses an
elimination reaction to cleave the glycosidic linkages in the polysaccharide (Fig.
1), resulting in unsaturated disaccharide products (41). These hyaluronidases,
found in bacteria and fungi, are known as hyaluronate lyases and are found in
species of Staphylococcus, Streptomyces, Clostridium, Propionibacterium, and
Peptostreptococcus and in Streptococcus groups A B C and G as well as
Streptococcus pneumoniae.
Streptococcus pyogenes produces two types of hyaluronate lyases. One
is phage-encoded, the other is chromosomal and the two share no significant
similarity in either nucleotide or amino acid sequence. The chromosomal
hyaluronate lyase of S. pyogenes, encoded by the hylA gene, while generally
considered to be a virulence factor, is certainly a spreading factor as its substrate
is a major component of the host extracellular matrix and a mechanism for
facilitating the spread of infection. The high viscosity of hyaluronic acid makes it
resistant to penetration and most pathogenic bacteria capable of colonizing skin
and mucosal sites produce a hyaluronate lyase enzyme (30).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

13

N-acetylgiucosamine

Glucuronic acid

CHaOH

COOH

COOH

CHzOH

1- 1-4

OH

1-3

1-3

■

OH

NHAc

OH

COOH

COOH

OH
OH
OH

NHAc

OH

NHAc

FIG. 1. The cleavage mechanism of the hyaluronate lyase of S.
pyogenes. The enzyme uses an elimination reaction to cleave the p i-4
glycosidic bonds of alternating N-acetylglucosamine and glucuronic acid residues
of the hyaluronic acid substrate.

The role of hyaluronate lyase in the pathogenesis of GAS is not
completely clear but may be two-fold. Recent results show that while the
presence of the enzyme has no effect on the spread of the bacteria into deeper
tissue, it is important for the diffusion of toxins and proteins produced by the
bacterium (66). Additionally, the disaccharide degradation products could
possibly be utilized for nutritional needs. This nutritional function of hyaluronate
lyase occurs in both gram negative and gram positive bacteria (36), and the
hyaluronate lyase permits the bacterium to utilize hyaluronic acid as an energy
source (47).
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Paradoxically, the capsule produced by S. pyogenes is composed solely
of hyaluronic acid and is considered to be a primary virulence factor. Why the
bacterium would produce an enzyme capable of degrading this defensive
structure is unknown, but not all strains produce capsule. Likewise, not all
strains produce a functional hyaluronate lyase. It remains to be shown whether
both functional enzyme and capsule are produced in any one strain of S.
pyogenes.
Genome sequencing has revealed that strains of S. pyogenes contain
multiple prophages that encode both proven and putative virulence factors.
Strains with published sequences contain from 4-6 prophage or prophage-like
elements, accounting for a majority of strain-to-strain variation in gene content
(49). Three full-length prophage sequences from the M-1 strain SF370 were
sequenced and shown to belong to the Siphoviridae family, which has long,
noncontractile tails. The ORF for the lyase HylP1 is annotated among the tail
fiber genes and the likely role for this and other bacteriophage lyases is to allow
phage penetration of the hyaluronic acid capsule during entry into the cell (63).
As was previously stated, there is little or no similarity in nucleotide or
amino acid sequence to the extracellular hyaluronate lyase produced by S.
pyogenes. The lyases also differ in molecular mass; while the bacterial
hyaluronate lyases range from 90-120 kDA, the bacteriophage lyases have a
much smaller mass, ranging from 36-40 kDa (47). Another difference is the
bacterial hyaluronate lyase contains a signal peptide for secretion to the
extracellular milieu while the phage lyase sequence contains no signal peptide.
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Any extracellularly detected bacteriophage lyase is likely a result of the liberation
of phage particles from lysogenic bacterial cells (35). One interesting similarity
that exists between the bacterial hyaluronate lyase and its bacteriophage lyase is
the nature of the cleavage reaction used to degrade the substrate. Both use the
same (3-elimination reaction as opposed to the hydrolysis reaction employed by
other hyaluronidases (47).
In addition to the extracellular Ziy/A-encoded hyaluronate lyase and the
bacteriophage-encoded hyaluronidases, another gene, Spy 1600 was putatively
identified as a hyaluronidase, based on homology to the Mu toxin of Clostridium
perfringens (25). But the gene lacks similarity to either hylA or the bacteriophage
hyaluronidase genes at either the nucleotide or amino acid level. Further,
studies indicate that the gene is incapable of producing an active enzyme, either
intracellularly or extracellularly (11).
The hylA gene of S. pyogenes is 2,604 bp in length and encodes an 868
amino acid protein. HylA has a molecular size of 99,646 Da and cleavage at the
putative signal peptide would result in an extracellular protein of 95,941 Da (32).
Complete genome sequences are now available for the following serotypes of S.
pyogenes: M-1, M-3, M-5, M-6, M-18, M-28 and M-49. Additionally, the
sequence for the hylA gene from strain 10403, an M-type 22 has been published
(32), allowing for the comparison of 8 hylA gene sequences from different
genotypes. Preliminary work has involved the sequencing and PCR analysis of
numerous strains of S. pyogenes, and from this as well as the analysis of
published genomes of S. pyogenes, three genotypes of hylA have been
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identified. First, there is the full-length hylA gene, which was described above.
All M-types 4 and 22 that have been examined contain the full-length hylA gene
and the protein produced by these strains is enzymatically active. In contrast,
the majority of genotypes of GAS contain a hylA gene that is either truncated at
the 3’ end or contains a conserved 186-base pair deletion near the 3’ end.
Neither of these genotypes produces a functional enzyme. While neither the M-1
nor M-3 serotypes appear to have an ezymatically functional HylA protein, these
strains have been tied to the most invasive forms of disease.

Regulation of S. pyogenes virulence factors. The mechanism of
regulation of the hylA gene has yet to be elucidated. Because of the large
number of virulence factors produced by S. pyogenes, coordination of expression
of genes controlling these factors involves a complex interplay of host signals
and transcription factors that respond to stimuli such as nutrient availability, pH,
osmolarity, growth phase, 0 2 tension, iron levels, temperature and the presence
of ions such as calcium and magnesium (65). During the initial stages of
infection, the bacterium must establish itself in either the respiratory tract or the
skin and evade the host immune response. This colonization requires adhesins
and other surface molecules that interact with host tissues, as well as molecules
designed to avoid or inactivate complement components and phagocytosis.
Later, when limited nutrients or other signals trigger what amounts to stationary
growth phase, another suite of factors that promote tissue damage and allow
dissemination into new host niches are expressed. This multifactorial nature of
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infection indicates a need for an orchestrated regulation of virulence genes in
response to changing environmental and temporal stimuli (58).
The transcription factors that mediate differential control of gene
expression either activate or repress initiation of transcription. Activators are
thought to recruit RNA polymerase to promoter regions by protein-protein
interaction and typically bind either just upstream or overlapping the promoter
region, facilitating interaction with the polymerase (4). Repressors typically bind
downstream of the promoter region, creating a physical impediment to the RNA
polymerase. While most prokaryotes employ multiple secondary RNA
polymerase sigma factors as a mechanism for responding to changes in
environment, only one such protein has been identified in S. pyogenes (54).
Genome sequencing of S. pyogenes has revealed at least 100 genes that
encode regulator homologues, including transcriptional regulators and twocomponent regulator proteins (30).
Only four stand alone regulators controlling S. pyogenes virulence have
been characterized thus far and these are Mga (multiple gene regulator), the
Nra/RofA-like protein family (RALP), Rgg/RopB (39) and Srv (streptococcal
regulator of virulence). While 13 two-component response regulator homologues
have been identified via genomic searches, only three of these have been
characterized in-depth; CovR/CovS, Ihk/lrr and FasBCAX. Two-component gene
regulatory systems are composed of a membrane-bound sensor kinase protein
and cytoplasmic response regulator protein, and are important mechanisms used
by bacteria to sense and respond to environmental stimuli. Because S.
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pyogenes pathogenesis is multifactorial and the bacteria encounter so many
environments during infection, the bacterium must be capable of changing its
repertoire of virulence factors, and in fact has been found to do so, using
pleiotropic regulatory networks, each controlling multiple virulence genes (44).

The Mga regulon. Because the M protein is central to virulence in S.
pyogenes, studies on control of expression began with this gene. The
transcriptional activator protein Mga, (originally referred to as Vir or Mry), was
initially discovered to be a positive regulator of the M protein, but has been found
to induce expression of many other cell-associated and secreted proteins
including adhesins, invasins, collagen-like protein, C5a peptidase, secreted
inhibitor of complement, serum opacity factor and other putative virulence factors
and proteins (39). Mga also activates its own expression (40). Recent
microarray analysis reveals that in some strains over 200 genes, equivalent to
10% of the genome of S. pyogenes, are affected by Mga, with equal numbers of
genes being repressed and activated. Repression is most likely accomplished
indirectly by the activation of negative regulatory elements (59).
Sequence homology occurs with phosphorlyation acceptor motifs on Mga,
suggesting that it may be part of a two-component signal transduction system,
but a sensor kinase has not been found associated with Mga. The genes
activated by Mga are expressed in late exponential growth phase and appear to
respond to CO2 and O2 levels, temperature, iron availability and osmolarity (42).
There does appear to be a link between Mga and metabolic growth. The majority
of genes Mga regulates function in energy metabolism, nutrient uptake and
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utilization, and protein synthesis, all of which reach maximal expression levels
during exponential phase and then rapidly decline during early stationary phase
(59).

Other “stand alone” regulators. In addition to Mga, three other “stand
alone” systems have been characterized in S. pyogenes. Like Mga, RALP and
Rgg/RopB have been designated as stand alone primarily because there has
been no sensor kinase or other sensory element identified.

In the case of these

regulators, little is known about how the environmental or growth-related signal is
sensed by the regulon. The RALP transcriptional regulator family is comprised of
four homologous proteins involved in S. pyogenes-host cell interaction,
avoidance of host defense and other virulence factors expressed during
stationary growth phase including hemolysins, proteases and superantigens.
The RALP proteins can function as either positive or negative regulators,
depending on which gene is being acted upon. Rgg/RopB can also exert either
positive or negative control, influencing particular proteases, adhesins, M protein
and autolysins as well as other regulons such as mga covR/S, fasBCAX and
ihk/irr (39). The srv gene was identified on the basis of its homology to the prfA
gene, a transcriptional activator of virulence found in Listeria monocytogenes.
The gene is conserved among most strains of S. pyogenes and its transcription
increased significantly in a serotype M1 strain lacking the mga gene, suggesting
a possible role in regulation of S. pyogenes virulence factors (56).
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Two component regulatory systems of S. pyogenes. Two component
signal transduction systems are commonly used to regulate the expression of
bacterial virulence factors in response to environmental stimuli. Upon sensing an
extracellular signal, the conserved histidine residue of a membrane-bound
sensor protein is autophosphorylated. The phosphoryl group is then transferred
to a cytoplasmic response regulator protein, altering its binding affinity and
thereby influencing transcription of genes or operons to mediate the cell’s
response to the original stimulus (26). Originally called CsrR-CsrS for capsule
synthesis regulator, the designation of CovR/CovS for control of virulence was
changed to when microarray analysis revealed its control over a large portion of
the genome. This regulator of virulence factors in S. pyogenes exerts either a
positive or negative influence on up to 15% of the characterized and putative
virulence factors in the bacterial genome, and is an important factor in moving
from the colonization to the invasive phase of infection (48). The regulated
genes include those which encode streptokinase, IgG protease, streptolysin,
streptodornase and the cysteine protease SpeB. In addition, CovR represses
expression of the hyaluronic acid capsule (27).

Many gram-positive bacteria

produce alternative sigma factors, including ctb, a protein that mediates the
binding affinity of RNA polymerase to allow the transcription of genes in response
to stress. But an orthologue of this protein has not been found in GAS and the
CovR/CovS two-component system possibly provides an alternative to this sigma
factor under conditions of stress (19).
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Other operons or regulatory proteins important to control of S. pyogenes’
myriad of virulence factors include fasBCAX, Nra and other RALPs, Ihk/lrr, RocA,
sag/pel and the RelA-independent response to amino acid starvation. The
fasBCAX operon and Ihk/lrr are both two-component regulatory systems;
fasBCAX is responsible for exerting control over virulence factors according to
growth phase while Ihk/lrr regulates expression in response to phagocytosis.
RALPs (RofA like proteins), including Nra, are grouped together on the basis of
similarity in function, mainly the regulation of surface proteins including
fibronectin and collagen-binding factors. The sag/pel regulon affects both
secreted and surface associated proteins and acts as a global regulator of
virulence. RocA (regulator of covR) acts to regulate levels of CovR by an as yet
unknown mechanism. And the RelA and RelA-independent regulators appear to
coordinate the ability of GAS to adjust to both amino acid-rich environments as
well as environments with more limited nutrients, where synthesis of
macromolecules becomes a necessity (30).

The regulation of hylA. Thus far, no regulator protein or regulatory
system has been linked to expression of the hylA gene. Published microarray
analyses do not mention any variation of hylA expression that is considered to be
significant (59, 62, 69). It does, however, appear to be expressed across
serotypes producing both the active and the inactive protein product, owing to the
fact that antibodies against hyaluronate lyase have been found in patients
infected with all M-types (28, 71).
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Transcript levels of hylA differ between active and inactive enzyme strains
as well as between capsular and acapsular strains. The M-22 strain 10403,
which produces an active enzyme, exhibits a bimodal pattern of expression (70);
levels increase in mid-exponential phase at 2-4 hours, decrease at around 6-8
hours and then increase again at hour 18. Two inactive enzyme strains, an M-1
and an M-28, also showed increased levels of hylA transcript at hour 6-8 but did
not exhibit the same bimodal pattern of expression as strain 10403. Additionally,
there was a significant difference in the quantity of transcript between the
acapsular M-1 strain and the encapsulated M-28 strain, which had transcript
levels greater than two times the amount of the acapsular strain (70).
So while it appears that there are differences in expression of hylA based
on serotype, and possibly associated with the presence or absence of both
capsule and/or an active hyaluronate lyase enzyme, neither the regulatory
mechanism for the gene’s expression nor the environmental stimulus that
triggers that mechanism has been elucidated. Clearly, further study in this area
is needed, and as the regulatory networks of S. pyogenes and their relationships
with one another are fully characterized, a complete picture of the coordinate
regulation of the many virulence factors, including hylA, expressed by this
pathogen will finally emerge.
The enzyme encoded by the hylA gene is probably not the most critical
to the bacterium’s success in infecting the host, as illustrated by the fact that
some of the more virulent strains of S. pyogenes encode a non-functional
enzyme. But because different serotypes of S. pyogenes cause different
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patterns of pathogenesis, it is worthwhile to characterize this gene in its various
forms and try to understand the relationship of these genotypes to the serotypes
in which they are found. And because of the interrelated complexity of the
regulatory networks found in S. pyogenes, it is unlikely that the hylA gene is
regulated in a solitary fashion. Rather it is likely to be expressed or repressed
along with other factors by some yet to be determined regulatory system, in
response to an environmental stimulus that is yet to be identified. In order to
develop new therapeutics against infection with S. pyogenes, including the
design of vaccines, the ultimate elucidation of this and all regulatory responses in
S. pyogenes will continue to be a priority.

Hypotheses and specific aims. There has been very little study of the
hylA gene of S. pyogenes. Some of the literature containing lists of S. pyogenes’
virulence factors includes the hyaluronate lyase encoded by hylA while others do
not. It is certainly a spreading factor; the breakdown of its hyaluronic acid
substrate allows for the spread of the bacteria’s toxins and other extracellular
products deeper into host tissue. It is likely that the carbon byproducts of this
degradation are used as a nutrient source. However, the mechanism of
regulation of the hylA gene is still unknown, and neither the protein(s) that affect
its transcription nor the environmental stimulus that triggers that mechanism have
been identified or elucidated. The aim of this project, therefore, was to help
clarify the role of hylA in the pathogenesis of S. pyogenes. First, a study of the
gene itself in its different forms and how these forms are associated with
serotype and disease pattern was undertaken. The hypothesis was that the
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structure of hylA is associated with serotype of S. pyogenes and therefore, with
disease pattern.
Second, the role of regulatory proteins that have the potential to control
expression of hylA was evaluated. The hypothesis was that expression of hylA is
controlled by a regulator of virulence factors. Genes encoding virulence
regulator proteins were knocked out by insertional mutagenesis, and the effect
on hylA expression was evaluated.

Because of the large number of serotypes,

virulence factors and disease patterns of S. pyogenes, and because the
regulatory networks utilized by S. pyogenes are so complex, a full understanding
of its pathogenesis still eludes researchers, in spite of the tremendous amount of
study devoted to this organism. But a complete picture must emerge if useful
strategies against infection with S. pyogenes are to be found.
These hypotheses were examined using the following specific aims:
1: Characterize the hylA gene from a large variety of S. pyogenes serotypes;
relate gene structure, i.e. truncations, deletions and nucleotide sequence, to the
expression of a functional HylA protein and to the severity of infection.
2: Characterize the regulation of expression of hylA in an M-4 strain of S.
pyogenes containing a full-length and functional gene by mutagenesis of
potential regulators of this mechanism.
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GENERAL LABORATORY METHODS AND MATERIALS

Equipment and Chemicals used. Unless otherwise noted in the body of
the text, equipment, chemicals, media and reagents used in these experiments
can be found in Appendix A.

Bacterial strains and media used. A complete list of bacterial strains
used can be found in Appendix B. All of the streptococcal strains came from
either Dr. Wayne L. Hynes, Old Dominion University or Dr. Sean D. Reid, Wake
Forest University, and are denoted by the prefix ODU or WF, followed by an
isolate number. Freezer stocks of S. pyogenes were stored at -80°C in Todd
Hewitt (Difco) broth containing 15% glycerol (Sigma).

Before use, freezer stocks

of S. pyogenes were plated on 5% sheep’s blood TSA agar (BD) and incubated
at 37°C in low 0 2 concentration. Freezer stocks of E. coli were stored at -80°C in
Luria Bertani (LB) (Difco) broth with 15% glycerol.

Media preparation. Media was prepared according to manufacturer’s
instructions. Todd Hewitt broth was prepared by dissolving 30 g of powdered
media in 1 L of deionized water and autoclaved. For Todd Hewitt agar, 1.5%
(w/v) granulated agar was added and dissolved prior to autoclaving. Any
antibiotics used were added to this mixture just prior to pouring aliquots of 20 ml
into 100 X 15 mm Petri dishes (Fisher), which were then stored at 4°C until
needed. LB broth and LB agar plates were prepared in a similar manner, using
25 g/L media
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Oligonucleotide primers used. Oligonucleotide primers used in this
work were purchased from Integrated DNA Technologies (IDT) unless otherwise
noted. A complete list of primers and sequences can be found in Table 1. The
primers were resuspended to a stock concentration of 100 pM in sterile,
deionized water, then diluted prior to use. For routine PCR amplification, 10 pM
primers were used; for nucleotide sequencing 2 pM was used. All resuspended
primers were stored at -20°C.

Hyaluronidase assays. All group A streptococcus strains used in the
epidemiology studies were assayed for enzymatic activity using BHB agar plates
containing 1% BSA, 3.7 g/100 ml Brain Heart Infusion (BD) and 2 pg/ml
hyaluronic acid, as previously described (33). A single bacterial colony was
transferred to the media with a sterile toothpick and stabbed into the agar in a
numbered grid pattern. The plates were incubated overnight in low O2 at 37°C.
The plates were then flooded with 2N acetic acid (Fisher), causing the hyaluronic
acid to co-precipitate with the BSA except in areas where the substrate had been
degraded. Enzymatic activity showed up as zones of clearing around the
colonies of strains that were positive for hyaluronate lyase production.

Milk plate preparation. Milk plates used for proteinase activity assays
were prepared by adding skim milk to Todd Hewitt agar to a final concentration of
1.5% (w/v) (31).
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TABLE 1. Oligonucleotide primers used.
Primer
Sequence 5’ to 3’
Epidemiology Studies
pJC2 A
GCC TTT GAG TGA GCT GAT AC
pRSET
CAC TGA CAG AAA ATT TGT GC
Hyl-GTG
GTG AAT ACT TAT TTT TGC AC
HylA-trunc2
CTA CGC CTT GTG AGA TGA C
Hyl-del
TTA CAT TGT TTT CTA ACA AGT CGA T
Hyl-1
GCT TAC ACT GGA GCT TAC GG
Hyl-TAG
CTA AAT CCT TAA GTC TTT CT
Hyl-10
ATC ATC AGA GAG GCT AGT CAT GC
Hyl-8
AGC AAA ACA GAT CAC TAA TCC TG
Hyl-9
AGT CCA AAA ACT TGA TAG TTA CGT AGC
Hyl-C
GAA CGC CCT CGA GTC ATA TC
Hyl-6
GGA GTT CCA ATT TCA TAA TC
Hyl-D
CAA AAG TAC CCT TAC TGT TC
Hyl-NoSignal
GCC GAT ACA CTG ACT TCA AAT TCA G
Hyl-M1 trunc
CTT TTA TTG CTG ATT TTG C
MP-1
TAT TSG CTT AGA AAA TTA A
MP-2
GCA AGT CTT CAG CTT GTT T
MP-seq
TAT TCG CTT AGA AAA TTA AAA ACA GG
Mutagenesis Studies
CovR-L
TAG TGA GAG AAA TCT CAT CG
CovR-L1
AAT CCT TTT GCT AGC TTG CA
CovR-R
TAT GAA GTC ATT GTT GAG GT
CovR-R1
AGG CAA TCA GTG TAA AGG CA
M13-1201 (pF)
AAC AGC TAT GAC CAT GAT TAC G
M13-1211 (pR)
GTA AAA CGA CGG CCA GT
Phage Hyaluronidase Studies
Hyl-P3
CTA TTT TTT TAG TAT GAG TTT TTT
Hyl-P4
CTT GAG GGT GAG ATA GGT TTT GAG
Site Directed Mutagenesis
HylA-3 T596A for
CAA AGA AAA TTG GTG GGA* TTA TGA AAT TGG AAC
HylA-3 T596A rev
GCA CGA GGA GTT CCA ATT TCA TAA TCC CAC CAA
* Indicates nucleotide changed
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Preparation of crude cell lysates. All S. pyogenes strains used were
cultured from freezer stocks onto BA plates as described, grown in Todd Hewitt
broth and incubated overnight at 37°C. The cells were then lysed using the
method described by Hynes (34) and these lysates stored at -20°C.

Agarose gel preparation. Agarose gels used to visualize DNA were
prepared by adding from 1% to 2% agarose to TBE buffer (6). For restriction
fragment length polymorphism (RFLP) studies, a mixture of 4% superfine
agarose in TBE buffer was used. For each, the mixture was heated in a
microwave oven until the agarose was completely melted and allowed to cool to
just above room temperature. Ethidium bromide was added to a final
concentration of 0.5 pg/ml and the liquid was poured into a gel-casting tray where
it solidified.
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METHODS FOR EPIDEMIOLOGY STUDIES

Characterization of the hylA gene by PCR. The hylA genes from the S.
pyogenes strains were initially characterized by PCR (polymerase chain
reaction). A list of PCR primers is found in Table 1. The components of the PCR
reaction for both the full-length hylA gene as well as the 3’ portion were: 1.5 pi
template, 0.5 pi each forward (10 pM) and reverse (10 pM) primer and 22.5 pi
Platinum Supermix (Invitrogen). The hylA genes from 32 S. pyogenes strains
previously shown to contain a deletion in the 3’ region were amplified using the
primer set Hyl-GTG and Hyl-TAG. For size comparison, the 3’ regions of hylA
genes were amplified with the Hyl-D and Hyl-TAG primers. In order to gain some
insight into the structure of the enzyme, different regions of the hylA gene from
strain 635-02 were amplified and cloned. The following primer sets were used:
Hyl-GTG and Hyl-TAG, Hyl-NoSignal and Hyl-TAG, Hyl-GTG and Hyl-M1 trunc
and Hyl-GTG and Hyl-dei.
For full length hylA amplification the following cycling parameters were
used: an initial denaturation of 94°C for 30 seconds was followed by 35 cycles of
94°C for 30 seconds, 50°C for 30 seconds and 68°C for 4 minutes. A final
extension of 68°C for 10 minutes was followed by a 4°C final hold. For PCR
amplification of the 3’ portion of the hylA gene, the following cycling parameters
were used: an initial denaturation at 94°C for 2 minutes was followed by 35
cycles of 94°C for 1 minute, 50°C for 1 minute and 72°C for 1 minute. A final
extension of 68°C for 10 minutes was followed by a 4°C final hold. Amplified
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DNA was electrophoresed at 150V and visualized on agarose gel prepared as
described above.

Site-directed mutagenesis of S. pyogenes strain 1055. Alignments
were made of the amino acid sequences of hylA genes from various S. pyogenes
M-types as well as the hyaluronate lyase gene from other species of
Streptococcus, S. agalactiae, S. pneumoniae and S. suis, as well as the
hyaluronate lyase from Staphylococcus aureus. Because these indicated a
difference of one amino acid between enzyme-producing M-22 and M-4 strains
and non-producing strains in an otherwise conserved region at the 5’ end of the
gene (see results), site directed mutagenesis was used to study whether this
change is responsible for the active/non-active enzyme phenotype. The M-type
3 strain 1055 was used, as the hylA gene from this strain had been previously
sequenced and the 3’ deletion confirmed. The gene was cloned into the TOPOTA pCRT7-NT expression vector. The plasmid was isolated from transformed E.
coli Top 10 F’ cells, which were grown in LB broth containing 50 pg/ml ampicillin.
Using the Quik-Change II system (Strategene) and mutagenic primers HylA-3
T596A Forward and HylA-3 T596A Reverse (changed nucleotide indicated in
table), the adenosine nucleotide in the second position of the codon being altered
was changed to a thymine, resulting in an amino acid change in the protein from
valine to aspartic acid.
The PCR reaction mix contained 5.0 pi Strategene 10X buffer, 1.25 pi
each forward and reverse primers (10 pM each), 1.0 pi dNTPs and 41.5 pi DNA
template in sterile, deionized H20 . Four reactions were prepared containing 5,
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10, 20 and 50 ng amounts of the DNA template. The cycling parameters were as
follows: an initial denaturation of 95°C for 30 seconds followed by 12 cycles of
95°C for 30 seconds, 55°C for 1 minute and 68°C for 6 minutes, concluding with
a hold at 4°C.
After completion of the amplification, Dpn\ restriction enzyme (10U) was
added to the reaction tube and digested at 37°C for 1 hour. The digested DNA
was transformed into 50 pi aliquots of XL1-Blue Supercompetent E. coli cells by
heat-shock at 42°C for 45 seconds followed by incubation in 500 pi SOC media,
shaking, for 1 hour. Liquid cultures were plated on LB agar containing 50 pg/ml
ampicillin and incubated at 37°C overnight.

Analysis of mutants. Transformants were assayed on BHB plates for
enzyme activity as described previously. Additionally, the nucleotide sequence of
the mutant gene was confirmed using Hyl-C as the sequencing primer. The
reaction mix and cycling parameters were the same as described previously.

PCR amplification of the hyIP and hylP2 genes from GAS strains. In
order to determine the correlation, if any, between the presence of bacteriophage
hyaluronidase genes in S. pyogenes with the hylA genotype, strains containing
the 3’ deletion in the hylA gene were compared to full-length hylA genes from Mtypes 4 and 22. These strains were analyzed by PCR for the presence of the two
known phage hyaluronidases genes, hyP and hyP2. A reaction containing 1 pi
each HylP-3 and HylP-4 primers (10 pM each) and 2 pi DNA template prepared
by heating a bacterial colony in 10 pi sterile, deionized H2Q at 95°C for 10
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minutes, and 22 pi Platinum Supermix. The following cycling parameters were
used: an initial denaturation at 94°C for 2 minutes was followed by 35 cycles of
94°C for 1 minute, 50°C for 1 minute and 72°C for 1 minute. A final extension of
68°C for 10 minutes was followed by a 4°C final hold.
Amplified DNA from the PCR reaction was electrophoresed at 150V for 1
hour on a 3% agarose gel. A 10 pi sample was loaded onto the gel.

Cloning of Aiy/A genes into plasmid expression vector and plasmid
sequencing vector. PCR-amplified hylA genes were cloned into either the
pCRT7®TOPO® TA Expression vector or the TOPO TA Cloning® vector for
sequencing (Invitrogen). The PCR product was incubated with the plasmid
vector and salt solution provided in the kit, and then transformed by heat-shock
at 42°C into chemically competent One Shot®Top10 E. coli. These linear
plasmid constructs contain an ampicillin resistance gene as well as T-overhangs
on either end which ligate to the A-overhangs on the PCR product that occur
during replication using Taq polymerase. The E. coli cells were incubated in
SOC medium and plated onto LB agar plates containing 100 pg/ml ampicillin.
Transformants were picked onto LB ampicillin master plates, incubated overnight
at 37°C and cultured in LB broth with 50 pg/ml ampicillin. The plasmids were
extracted using either the rapid plasmid extraction method (6) or the Wizard®
Plus SV minipreps DNA Purification System (Promega). When the expression
plasmid vector was used, the insert was screened for forward orientation using a
restriction enzyme digest containing 5 pi DNA, 10 pi sterile water, 2 pi React 2
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buffer and 0.2 pi Hind\\\ enzyme (Invitrogen). The reaction mixture was
incubated in a water bath at 37°C for one hour after which 5 pi was loaded into
the well of a 1% agarose gel and electrophoresed so that the size of the digested
product could be visualized.

Sequence analysis of hylA genes. For nucleotide sequencing, the
entire hylA gene from the examined strains were cloned into either the pCRT7NT plasmid vector or the TOPO TA cloning vector. Overlapping fragments were
sequenced using the ABI Genetic Analyzer 3130x1. Primers used were Hyl-GTG,
Hyl-1, Hyl-10, Hyl-8, Hyl-9, Hyl-6, Hyl-C, Hyl-D and Hyl-TAG as well as the
plasmid primers pJC2A and pRSET. Figure 2 shows a schematic drawing of the
hylA gene and primer locations as well as a map of the plasmid vector used for
cloning. The Applied Biosystems BigDye protocol was followed for sequencing
and the reaction was composed of 2.4 pi BigDye terminator 5.4 pi 10X buffer, 8
pi H20 , 2 pi DNA template and 2 pi primer (10 pM). The following cycling
parameters were used: 96°C for 30 seconds, 55°C for 10 seconds and 60°C for 4
minutes repeated 25 times, followed by a 4°C hold. Additionally, a ramp speed
of 1°C per second between cycle temperatures was programmed.

Analysis of nucleotide sequences. Sequence alignments were
generated using the Vector NTI software suite (Informax) and phylogenetic trees
were generated using PAUP software.
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Hyl-C

Hyl-9
Hyl-10

Hyl-1

HylA

Hyl-6

Hyf^D

Hyl-8
Hyl-no signal

Hyl-del
Hyl-trunc

Hylatg

Hyl-tag

Hyl-gtg

hylA
FIG. 2. The hylA gene of S. pyogenes. The location of forward and
reverse primers are shown.

T7 promoter
RBS
Initiation ATG
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Express epitope
Bam H I (193)

TOPO cloning site
£coR I (212)

A p a L l (2379)

pUC origin

/ / in d ll l (219)

pRSET reverse priming site

PCRT7/NT-TOPO

T7 transcription termination

2870 bp

f1 origin
Invitrogen

A p a U (1133)

Amp R gene

FIG. 3. Plasmid map of cloning vector pCRT7/NT-TOPO.
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Characterization by emm typing. A portion of the gene encoding the M
protein, including the hypervariable sequence responsible for encoding M
serospecificity, was amplified by PCR, as described by the CDC. The
components of the PCR reaction mix were: 1 pi DNA template, 5 pi 10X buffer
(Promega), 3 pi 25 mM MgCI2 (Promega), 1 pi 10 mM dNTP mix, 1 pi MP1
primer, 1 pi MP2 primer (IDT), 38 pi H20 and 0.3 pi Taq polymerase. The
reaction mix was amplified using the following program: After an initial
denaturation of 1 minute at 94°C, there were 10 cycles of 94°C for 15 seconds,
46.5°C for 30 seconds and 72°C for 1 minute 15 seconds. This was followed by
20 cycles of 94°C for 15 seconds, 46.5°C for 30 seconds and 72°C for 1 minute
15 seconds with a 10 second increment for each of the subsequent 19 cycles.
Finally, one cycle of 72°C for 10 minutes was followed by a hold temperature of
4°C.
The PCR reactions were purified using the Wizard PCR Prep kit and
sequenced using the MP-Seq primer using the same Applied Biosystems
protocol as described previously. Nucleotide sequences obtained were then
entered into the Streptococcus pyogenes emm sequence database maintained
by the CDC at http://www.cdc.gov/ncidod/biotech/strep/strepblast.htm for emmgenotyping.

RFLP analysis of the emm gene. The emm genes from GAS strains
were also characterized by restriction fragment length polymorphism analysis.
The digest reaction containing 10 pi PCR product and I pi Dcfel restriction

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

36

enzyme and was incubated in a 37°C water bath overnight and visualized on a
4% superfine agarose gel to compare banding patterns.
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METHODS FOR REGULATION STUDIES

Bacterial strains, plasmid vectors and media used in regulation
studies. The parent strain of S. pyogenes used in regulator insertional
mutagenesis studies was the M-type 4 strain 635-02. For these studies the
response regulator plasmid constructs listed in Table 2 were utilized. The
constructs contain a portion of the regulator gene and an erythromycin resistance
cassette in a temperature-sensitive backbone (57). These plasmids were
provided by Kevin S. Mclver, University of Maryland, Baltimore, MD. Freezer
stocks of DH5a E. coli containing the plasmids were plated on LB agar containing
500 pg/ml erythromycin and incubated overnight at 37°C. The bacteria were
then cultured in 500 ml of LB broth containing 500 pg/ml erythromycin. The
plasmids were extracted using the Wizard® Plus SV Maxi-preps DNA Purification
System. After electroporation of plasmid DNA into S. pyogenes, the bacteria
were selected and maintained in either Todd Hewitt broth or on Todd Hewitt agar
containing 1 pg/ml erythromycin.

Dr. Mclver also provided cultures of S.

pyogenes parent strain GA40634 and KSM547, a mutant of this strain that
contains an mga gene that has been knocked out by insertional mutagenesis
(59).

Confirmation of covR and other two-component response genes in
S. pyogenes strain 635-02. To confirm the presence of the covR and other twocomponent response regulator genes in strain 635-02 of S. pyogenes, an internal
portion of the genes was PCR amplified from crude cell lysate using the primers
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CovR-L1 and CovR-R1 and the other two-component response regulator primer
sets. The following cycling parameters were used: an initial denaturation at 95°C
for 10 minutes was followed by 35 cycles of 95°C for 1 minute, 50°C for 1 minute
and 72°C for 2 minutes. A final extension at 72°C for 10 minutes was followed by
a hold at 4°C. The PCR product was electrophoresed on a 1% agarose gel at
150V with 10 pi loaded into wells, for visualization of the DNA.

TABLE 2. Mutagenic plasmids containing portions of S. pyogenes twocomponent response regulator genes.
Mutagenic Plasmid

S. pyogenes Gene

p233-1R

fasB

p233-2R

covR

p233-4R
p233-5R
p233-6R
p233-7R

strR

p233-8R
p233-9R
p233-10R
p233-11R
p233-12R
p233-13R

irrR
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Insertional mutagenesis of the covR and other response regulator
genes in S. pyogenes.
were

prepared

Electrocompetent cells of S. pyogenes, strain 635-02

by growing

an overnight culture

in Todd

Hewitt broth

supplemented with 5% horse serum at 37°C. Cells were diluted 1:50 and grown
to mid-log phase or to an OD6oo of 0.2, pelleted by centrifugation at 7,000 X g for
10 minutes, washed and resuspended in 1 ml 0.5M sucrose solution. The cells
were then washed 4 times by centrifugation at 14,000 X g for 1 minute and
resuspended in 1 ml ice-cold 0.5M sucrose. After the final wash the cells were
resuspended in 100 pi of ice-cold 0.5M sucrose and stored on ice.
Plasmid DNA (1-5 pi) was mixed with 40 pi electrocompetent S. pyogenes
cells and transferred to a pre-chilled 0.2 cm electroporation cuvette. Using the
Transporator Plus (BTX), a current of 2.5 kV was applied. One ml Todd Hewitt
broth was added and the cells were then incubated at 30°C for 2 hours before
spreading onto Todd Hewitt agar plates containing 1 pg/ml erythromycin. The
spread plates were incubated overnight at low 0 2 concentration at 30°C.
Electrotransformants were picked into Todd Hewitt broth containing
erythromycin and incubated overnight at reduced 0 2 concentration at 30°C. The
broth culture was diluted 1:100 with fresh Todd Hewitt/erythromycin broth and
incubated overnight at low 0 2 concentration at 37°C, after which a loop full was
T-streaked onto Todd Hewitt/erythromycin.
PCR analysis of transformants. Colonies were PCR-screened for
successful insertional mutagenesis using the following primer combinations:
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CovR-R/CovR-L, Plasmid Forward/Plasmid Reverse, CovR-R/Plasmid Forward,
CovR-R/Plasmid Reverse, CovR-L/Plasmid Forward and CovR-L/Plasmid
Reverse (Fig. 4). The PCR product was electrophoresed on a 1% agarose gel at
150V with 10 pi of sample loaded into wells.

Primers
L
R
pF
pR

pR

Gene left
Gene right
Plasmid forward
Plasmid reverse

pF

FIG. 4. Insertional mutagenesis using the p233 mutagenic plasmid. The
erythromycin cassette is shown in blue. The response regulator gene, which has
been interrupted by the plasmid, is shown in green, with the area of homology
between the plasmid and gene shown in purple.

With correct insertion of the plasmid into the gene, the gene specific
primer set (L and R) will not amplify, as the fragment is too large because of the
p233 plasmid backbone (over 5,000 bp). Plasmid primers pF and pR will not
amplify either, as the plasmid will have integrated into the chromosome.
Depending on the orientation of the insertion, either pF/ R and pR/L or pF/L and
pR/R will amplify a fragment that can be visualized on agarose gel.
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Enzyme assay of inactivated genes product. Electrotransformants that
yielded a positive PCR result for one of the CovR and Plasmid primer
combinations or other response regulator primer combinations and a negative
result for the CovR-L/CovR-R or other response regulator primer combination
were assayed on BHB plates to determine whether a loss of enzymatic activity
had occurred as a result of the mutation of the covR gene.

Additional assays of electrotransformants. Electrotransformants which
tested positively for gene knockout as described above were also assayed for
loss of hemolytic activity and loss of proteinase activity. For the hemolysis assay
a blood agar plate was stabbed with an electrotransformant colony and incubated
at 37°C overnight in a candle jar. A zone of clearing around the colony is an
indication of hemolysis.
For the proteinase activity assay, a Todd Hewitt/milk plate was stabbed
with an electrotransformant colony and incubated at 37°C overnight in a candle
jar. As in other assays, a zone of clearing around the colony is an indication of
proteinase activity.

Assay of the effect of inactivation of mga on S. pyogenes M-4 strain
GA40634. In order to determine the affect of the regulator protein Mga on
expression of the hylA gene, the M-4 parent strain GA40634 and a mutant of this
strain containing an inactivated mga gene were both assayed for hyaluronate
lyase enzyme activity. Prior to this assay, the mga gene from both strains was
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PCR amplified to ensure that the gene was present in the wild type and the
inactivated mutant.
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RESULTS OF EPIDEMIOLOGY STUDIES

Assay for hyaluronate lyase enzyme activity. All strains of S.
pyogenes used in this study were assayed for enzymatic activity. A summary of
enzyme activity as correlated by M-type is shown in Table 3. A comprehensive
list of all strains with accompanying serotype information and enzyme activity
assay results can be found in Appendix C. The zone of clearing around a
bacterial colony (Fig. 5) indicating a positive result was measured on a relative
scale and ranked (+) to (+++) for smallest to largest clear zone. Strains
expressing bacteriophage hyaluronidase exhibited a minimal zone of clearing
and these are noted by (+/-).

TABLE 3. Results of hyaluronate lyase enzyme assays of all M-types studied.
Extracellular enzyme activity

M-type

Positive (++, +++)*

4, 22

Negative (-, +/-)

1, 2, 3, 5, 6, 9, 11, 12, 18, 32, 41, 43, 58, 73,
75, 77, 78, 82, 83, 84, 85, 87, 89, 92, 94, 96,
114

* indicates relative amounts of enzymatic activity
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FIG 5. The bacteriophage-encoded hyaluronidase produced by S.
pyogenes. Enzymatic activity is indicated by a minimal zone of clearing in clones
2, 3, and 5. The hylA gene from these same clones, when expressed in E. coli,
shows no enzymatic activity. Colonies 1-5 are M-3 strains containing the hylA
deletion structure and 6-10 are the hylA gene from the same strains expressed in
E. coli in the pCRT7-NT cloning vector. A: Positive control M-22 strain 10403
containing the full-length hylA gene. B: Positive control strain 10403 cloned into
the same expression vector.

Characterization of the hylA gene. The hylA genes from five M-4
strains, five M-type 22 strains and 7 M-type 3 strains were cloned into the
pCRT7-NT expression vector and analyzed by nucleotide sequencing. These
results revealed two hylA gene structures. The first is 2,607 bp in length from the
start codon GTG to the stop codon TAG and will be referred to as hylA fulllength. The second structure type has a conserved, 183 bp deletion in the 3’
portion of the gene and will be referred to as hylA deleted. This deletion is in
frame and encompasses the region from base pair 2,273 to base pair 2,456 in
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the hylA full-length gene. Analysis of the hylA genes from other M-types of S.
pyogenes which have been posted on GenBank revealed a third structure which
contains a premature stop codon in the 3’ region of the gene at base pair 2,415,
which results in a truncated protein being translated. This structure will be
referred to as hylA truncated. These three structures are shown in Fig. 6.
As a preliminary assessment of gene size, a portion of the hylA gene of
some strains was PCR amplified using the primers Hyl-D and Hyl-TAG. The
fragment amplified encompasses the 3’ region of the hylA gene and gives an
indication of the size difference between the hylA full-length structure and the
hylA deleted structure (Fig. 7). Truncated strains would show the same size band
as the full length gene.

Characterization of the hylA gene from S. pyogenes strain 635-02.
Portions of the S. pyogenes strain 635-02, which contains the hylA full-length
structure, were PCR-amplified using four primer sets. Hyl-GTG and Hyl-TAG
amplify the full-length hylA structure. Hyl-NoSignal and Hyl-TAG amplify a
fragment that represents the hylA gene with the putative signal peptide removed.
Hyl-GTG and Hyl-M1 trunc primers amplify the portion of the gene representing
the hylA truncated structure. Finally, the Hyl-GTG and Hyl-DEL primer set
amplifies a gene fragment representative of the hylA up to the point of the
deletion seen in M-3 strains. The gene fragments were cloned into the pCRT7NT expression vector, checked by nucleotide sequencing and assayed for
enzymatic activity.
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5’

3’
TAG

GTG
2273

hylA Full-length

2456

183 bp

2,607 bp

TAG

GTG

hylA Deleted

2,493 bp
TAA

GTG

hylA Truncated

2,418 bp

FIG. 6. Three structures of the hyaluronate lyase gene, hylA, from S. pyogenes.

FIG. 7. Size difference of 3’ region of hylA. Shown are PCR amplified
regions of the gene containing the hylA full-length and hylA deletion structures.
Lanes 2-5 and 7 are M-3 strains while lane 6 is M-22 strain 10403, which
contains the full-length hylA gene. Lanes 1, 8: 50 bp MW.
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Figure 8 shows a schematic of the gene fragments with enzyme assay
results. The assays indicated enzymatic activity for fragments amplified by
primer sets: Hyl-GTG/Hyl-TAG, Hyl-NoSignal/Hyl-TAG and Hyl GTG/Hyl-M1
trunc. No activity was seen in clones containing the fragment amplified by the
Hyl-GTG/Hyl-del primer set. The cloned gene fragments were sequenced to
confirm presence and correct orientation in the expression vector. There were
no changes to the original nucleotide sequence.

GTG

TAG

Hyl-GTG/Hyl-TAG

GTG

TAA

Hyl-GTG/Hyl- Del

Hyl-GTG/Hyl-M1 Trunc

GCC

TAG

Hyl-GTG/Hyl-NoSignal

FIG. 8. Hyaluronate lyase enzymatic assay results of S. pyogenes strain
635-02 hylA gene fragments. The fragments were cloned into the pCRT7-NT
expression vector prior to enzymatic assay.
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Alignments of hylA amino acid sequences. Alignments of the hylA
gene sequences and respective translated proteins were carried out to compare
the nucleotide and amino acid sequence similarities of hylA genes. Using
GenBank sequence data, overall nucleotide sequence similarity among the hylA
genes was 76%. At the amino acid level the similarity was 73.4%. This
represents overall similarity and includes the regions deleted and truncated
which decrease the similarity. Incorporation of the 17 strains sequenced in this
study along with the sequence of hylA genes/proteins from the other M-types of
S. pyogenes as well as the hyaluronate lyase genes from S. agalactiae, S.
pneumoniae and Staphylococcus aureus showed there was variation throughout
the sequence, even within serotypes. However, the amino acid at position 199 of
HylA is an aspartic acid in enzymatically active strains of S. pyogenes (Fig. 9).
The aspartic acid residue is also conserved in the sequence of the hyaluronate
lyases of S. agalactiae, S. pneumoniae, S. suis and Staphylococcus aureus, all
of which produce an active hyaluronate lyase or hyaluronidase (Fig. 9). In the
enzyme-negative strains of S. pyogenes, the residue at this position is a valine,
and again, is consistently so among all these strains. It is the only amino acid in
the alignments of the hyaluronate lyase translated products to show consistent
difference between the enzyme-negative and enzyme positive strains and
species.
An additional comparison of the 3’ region of the hylA genes from two M-1
sequences and two M-4 sequences was made at this time. This was done in
order to determine whether there were significant differences in the region
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between the start of the deletion found in the deleted form of hylA and the
premature stop codon found in the truncated form of hylA. Three changes were
noted: a lysine residue in the M-4 sequence changed to an arginine residue in
the M-1, a glutamate residue in the M-4 changed to a glycine in the M-1 and a
threonine residue in the M-4 changed to a methionine in the M-1 amino acid
sequence.
199
M-22 strain 10403
M-22 strain 437
M-22 strain 4786
M-22 strain 3200
M-22 strain 6219
M-4 strain 2397
M-4 strain 4282
M-4 strain 445
M-4 strain 4283
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M-1 strain SF370
M-1 strain MGAS5005
M-3 strain MGAS315
M-2 strain MGAS10270
M-5 strain Manfredo
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M-12 strain MGAS9429
M-18 strain MGAS8232
M-28 strain MGAS6180
M-3 strain 872
M-3 strain 1055
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FIG. 9. Amino acid alignments of the 5’ region of the hylA gene. Shown is
area encompassing the amino acid at position 199. Sequences are from
enzyme-positive and enzyme-negative S. pyogenes strains and the hyaluronate
lyase gene from S. agalactiae, S. pneumoniae, S. suis and Staphylococcus
aureus. The amino acid residue at position 199 is aspartic acid in enzymepositive strains and species, and valine in enzyme-negative S. pyogenes strains.
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Protein modeling of the hylA gene. Based on the structural analysis of
S. agalactiae and S. pneumoniae, initial modeling of the hylA gene from S.
pyogenes in its native conformation suggests that the amino acid located at
position 199 resides within a cleft, or pocket that is a potential active site for the
enzyme (Fig. 10).

FIG. 10. Three dimensional model of the hyaluronate lyase protein from S.
agalactiae. The putative active site can be seen opening from the bottom of the
protein (37). The amino acid residue at position 199 of HylA is shown in red and
appears to reside deep within the pocket. The protein was viewed with Rasmol
version 2.7.2.1.1 software.

Results of site-directed mutagenesis of S. pyogenes strain 1055.
Site-directed mutagenesis was carried to determine the effect of a change in the
am ino acid of the hylA gen e at position 199 o f th e S. p y o g e n es strain 1055. As

with all other enzymatically-negative strains that were examined, this residue is a
valine. By mutating one nucleotide, the adenosine in the central position of the
valine codon, to a thymine, the result was a change of amino acid to aspartic
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acid. The mutagenesis was verified by nucleotide sequencing. An assay for
enzymatic activity was performed and the result was negative.

RFLP analysis of the emm gene from hylA deleted S. pyogenes
strains. The method employed by the CDC for emm-genotyping of S. pyogenes
strains compares sequences of the hypervariable portion of the emm gene,
which encodes the M protein. Restriction fragment length polymorphism analysis
gave an indication of the variation in the gene portion, based on the different
banding patterns of the digest DNA, as visualized on agarose gel. This allowed
for grouping of strains based on digestion patterns
The hypervariable portion of the emm genes of 32 strains from the ODU
collection were subjected to RFLP analysis. The strains all had a smaller hylA
gene as indicated by PCR amplification of the 3’ region. The results of these
experiments are shown in Fig. 11.

Characterization of S. pyogenes isolates by emm-genotype. The
thirty two isolates from the ODU collection, chosen on the basis of prior PCR
analysis that revealed the deletion in the 3’ portion of the hylA gene, were emmgenotyped. The results of this analysis are shown in Table 4.
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FIG. 11. RFLP analysis of the emm gene. Thirty-two ODU strains of S.
pyogenes containing the hylA deleted structure were studied (see Table 4). A:
Lane 1 50 bp MW marker. Lanes 2-11 and 14-16 are M-type 3 strains. B: Lanes
1-16 are various M-types other than M-type 3, as seen by variation in banding
pattern. The restriction enzyme DdeI was used to digest the hypervariable
portion of the emm gene. MW marker lanes not shown due to the high intensity
of the bands; this would not allow visualization of the digestion bands.
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TABLE 4. Emm-genotype results of 32 ODU S. pyogenes hylA deletion
strains.
Strain

emm-Genotype

ODU-114

3

ODU-380

3

ODU-1045

3

ODU-422

3

ODU-872

3

ODU-1020

3

ODU-1055

3

ODU-94146

3

ODU-95-4383

3

ODU-CGH 97-1

3

ODU-871

3

ODU-880

3

ODU-1074

3

ODU-869A

3

ODU-869B

3

ODU-350

3

ODU-462

17

ODU-777

17

ODU-600

5

ODU-364

5

ODU-1013

18

ODU-440

12

ODU-92

9

ODU-7

78

ODU-58

75

ODU-788

32

ODU-703

43

ODU-795

ST 3765

ODU-389

STG 5420

ODU-944

STC 839

ODU-561

STG 166B

ODU-250

STCK 401
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PCR amplification of hyIP and hylP2 genes from GAS strains. The
genes for two bacteriophage-encoded hyaluronidases found in some S.
pyogenes genomes were PCR amplified in order to determine if there is a
correlation between the presence of phage encoded hyaluronidase and
chromosomal hyaluronate lyase. All 32 ODU strains showing the hylA deletion
structure were analyzed as were all M-4 and M-22 strains which have been
shown to contain the hylA full-length structure.
Results, as shown in Figure 12, indicated the presence of one or both
phage hyaluronate lyase genes in all hylA deleted strains and the majority of the
M-22 and M-4 strains.

Phylogenetic analysis of hylA and emm gene nucleotide sequences.
Nucleotide sequences of the hylA and emm genes from strains exhibiting the
hylA deletion structure and the hylA full-length structure were analyzed on the
basis of their phylogenetic relationship. When the hylA genes from the 17 ODU
strains which were cloned and sequenced are compared, the resulting
dendrogram (Fig. 13) shows the enzyme-positive strains (M-types 4 and 22) form
a separate clade from the enzyme-negative M-type 3 strains. The latter are more
closely related to other enzyme-negative S. pyogenes M-types.
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FIG. 12. PCR amplification of the hylP and hyP2 genes from S.
pyogenes. Lane 1 on both gels is 50 bpMW marker. A: Strains containing the
hylA deletion gene structure. Lanes 2-11: S. pyogenes strains 462, 777, 600,
364, 1013, 440, 92, 58, 795, 788 and 703. B: Strains of M-types 4 and 22,
shown to have the hylA full-length structure. Lanes 2-11: S. pyogenes strains
4282, 3200, 445, 6219, 2397, 4282, 3779, 4786, 437 and 422. The primer set
HylP-3 and HylP-4 amplifies both genes.
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FIG. 13. Phylogenetic analysis of the hylA gene sequence. The neighborjoining bootstrap tree of the nucleotide sequence of genes to base pair 2,272, the
region not encompassing the 183 bp deletion was used. 100 bootstrap replicates
were analyzed, using PAUP software. The hyaluronate lyase gene sequences of
S. agalactiae (spa) and S. pneumoniae (spn) were obtained from GenBank and
used as outliers. Sequences from the M-1, M-18 and M-5 genomes,
representing the hylA truncated structure were also obtained from GenBank.
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RESULTS OF REGULATION STUDIES

Confirmation of the covR gene in S. pyogenes strain 635-02. The M-4
strain 635-02 of S. pyogenes was confirmed to contain the covR gene. Crude
cell lysate used as template was PCR-amplified using the CovR-L1/CovR-R1
primer set and the resulting product, as visualized on agarose gel, was
approximately 1,092 bp in length (Fig. 14).

Insertional mutagenesis of the covR gene in S. pyogenes strain 63502. Electroporation of the mutagenic plasmid p233-2R into competent S.
pyogenes cells resulted in disruption of the gene as a result of the insertion of the
entire plasmid backbone into the gene. The plasmid’s insertion into the gene
was confirmed by PCR amplification of the covR gene from electrotransformant
colonies that had been successfully screened using the erythromycin antibiotic in
the growth media. The amplification resulted in no visible bands on an agarose
gel. Because the entire plasmid backbone of greater than 5,000 base pairs is
inserted into the gene along with the homologous region, the resulting “knock
out” gene is too large to PCR-amplify.
The presence of the plasmid is confirmed by using combinations of gene
and plasmid primers that result in amplification of regions that can be visualized
on an agarose gel. This PCR screening on electrotransformants was carried out
using the primer sets: M13-1201/M13-1211 (plasmid pF and pR), CovRR1/CovR-L1, CovR-R1/pF and CovR-L1/pR. The parent strain was amplified
using the CovR-R1/CovR-L1 primer set as a positive control and the pF/pR
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primer set as a negative control (Fig. 15). The knockout strain will be referred to
as 635covR.

FIG. 14. PCR-amplification of the covR gene from S. pyogenes strain
635-02. Lane 1: covR. Lane 2: X-Sty MW marker.
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FIG. 15. Confirmation of the insertion of mutagenic plasmid. The p233-R2
construct was inserted into the covR gene of S. pyogenes strain 635-02. Lane 1:
X-Sty MW marker; Lane 2: Parent strain covR gene amplified with CovRR1/CovR-L1; Lane 3: Parent strain with pF/pR; Lanes 4-7: Electrotransformants
amplified with CovR-R1/Cov-L1, pF/pR, CovR-R1/pF and CovR-L1/pR.
Combinations of plasmid and gene primers result in amplification in a successful
knockout, while the gene primer set cannot amplify the gene with the large insert.

Enzyme assay of 635covR. The S. pyogenes knockout strain 635covR
was assayed for enzymatic activity on BHB agar. Four colonies were stabbed
into the agar along with a colony of the parent strain 635-02 as a positive control.
All four colonies show no difference in the size of the zones of clearing, indicating
enzyme production by the knockout strain (Fig. 16). No difference was seen
between the parental strain and the mutants.

Insertional inactivation of SPT9R and SPT12R in S. pyogenes strain
635-02. Mutagenic plasmid constructs containing an internal portion of 12
response regulator genes were obtained for insertional mutagenesis studies. Of
these genes, fasA, covR, strR and irrR, have been characterized and confirmed
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FIG. 16. Enzyme assay of S. pyogenes strain 635-02 covR knockout. C:
Positive control using parent strain 635-02. I-4: Four colonies of covR knockout
strain.

as the response regulator component of a two-component regulation system.
The remaining eight are putatively identified as response regulator genes based
on homology to genes encoding proteins of similar function.
The presence of all 12 genes in the genome of S. pyogenes strain 635-02
was confirmed by PCR (Fig. 17) and in addition to covR, two others were
successfully inactivated using the same methods. SPR9R and SPT12R were
knocked out using mutagenic plasmids p233-9R and p233-12R. The knockout
strains are referred to as 635spt9 and 635spt12. Inactivation was confirmed by
PCR, which showed the presence of the plasmid backbone within the gene. Both
mutants were enzyme-positive Enzyme titer assays of the knockout strains were

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

61

conducted on BHB agar and the knockout strains showed no change in
enzymatic activity, (Fig. 18).

Additional assays of 635SPT knockouts. In addition to the enzymatic
activity assay, 635spt9 and 635spt12 knockout strains were assayed for protease
activity and hemolysis. Neither phenotypic trait appeared to be affected by loss
of the regulator genes’ activity (Figs. 19 and 20). Mutant 635covR also showed
no difference in protease or hemolytic activity.

FIG. 17. PCR amplification of response regulator genes in S. pyogenes
strain 635-02. Lane 1: A,-Sty MW marker. Lane 2: SPTR1; Lane 2: SPTR2;
Lanes 3-13: SPTR4-SPTR12. Primers were gene specific L and R.
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FIG. 18. Enzymatic activity assay, on HA agar plates. Clones of 635spt9
and 635spt12 were used, with the 635-02 parent strain as a positive control.
Two-fold serial dilutions made from supernatant from overnight broth cultures
were pipetted into pre-cut wells in the agar. Center wells: Undiluted. Outside
wells clockwise from top: Dilution factors of 2, 4, 8, 16, 32, 64, 128 and 256.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

63

FIG. 19. Protease activity assay on milk agar plate. 635spt9 and
635spt12 showed little, if any, change in proteolysis of milk from the control;
parent strain 635-02.

FIG. 20. Hemolysis assay of 635spt9 and 635spt12 on blood agar plate.
The two knockout strains do not appear to have a loss of hemolytic activity as a
result of the gene inactivation.
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Results of inactivation of mga in the M-4 strain GA40634. The
enzyme assays of cultures of the M-4 parent strain GA40634 and its mutant form
KSM547, which lacks a functional mga gene, showed no differences (Fig. 21).

FIG. 21. Results of enzyme assay on mga knockout. 1: The parental S.
pyogenes M-type 4 strain (GA40634) 2: The mga knockout strain (KSM547).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

65

DISCUSSION

The impact of S. pyogenes and the diseases it causes. The global
burden of infection caused by S. pyogenes is tremendous. The myriad types of
diseases caused by this pathogen create enormous economic hardship,
particularly in developing countries, where both invasive and self-limiting
infections are more prevalent (16). An effective vaccine against infection with S.
pyogenes has yet to be designed, so there continues to be a great deal of
research effort directed towards this end, as well as towards improvements in
clinical treatments of infection.
The variety and magnitude of disease caused by S. pyogenes is likely due
in no small part to the fact that the bacterium expresses so many virulence
factors. These proteins, enzymes, and toxins, controlled by a complex network
of regulatory proteins and signaling cascades, are stimulated by changes in the
pathogen’s environment in an exquisitely coordinated response. Among these
proteins, the hyaluronate lyase enzyme has been relatively uncharacterized. It
was the goal of this project to add to the understanding of this enzyme and the
role it plays in the virulence of S. pyogenes, and perhaps in doing so to add to
the overall understanding of this pathogen and the many diseases it causes.

Characterization of the hylA gene. Previous studies on the hylA gene of
S. pyogenes conducted in this lab indicated that the gene structure can vary
among serotypes. Strain 10403, the prototype hyaluronate lyase producer is
known to produce an enzymatically active hyaluronate lyase; the hylA gene from
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this strain has been sequenced and published (32). In a survey of the hylA gene
from strains of various serotypes, it was discovered that some contained an in
frame deletion of 183 base pairs at the gene’s 3’ end (70). Additionally, a third
hylA gene form is found in the chromosomal sequences of M-1, 2, 5, 6, 12, 18,
and 28 serotypes deposited in GenBank. This form contains a premature stop
codon, resulting in a truncated protein. Therefore, three gene structures have
been characterized, a full-length gene, a gene containing an in-frame deletion
and a full-length gene containing a premature stop codon (Fig. 6).
Because it is widely accepted that there is a degree of specificity among
serotype, disease and host tissue, one of the aims of this project was to
determine whether there is any correlation of the hylA gene structure to serotype
and hence, to the characteristic pathogenesis of the infection caused by a
particular serotype. In order to do so, a comprehensive analysis of 227 strains of
S. pyogenes was undertaken in which the hylA gene was characterized in terms
of its structure, its ability to produce an active enzyme, its serotype and the
similarities in sequence at both the nucleotide and the amino acid level.
Initially, 16 strains of S. pyogenes were examined. Nine of these were
from either M-type 4 or 22, which produce an enzymatically active HylA protein.
The remaining 7 strains were hyaluronate lyase-negative and were of unknown
serotype. These strains had been screened by PCR and found to contain hylA
genes with a deletion at the 3’ end of the gene (70). After cloning and
sequencing the hylA gene from all 16 strains, enzymatic assays were performed
on both the parental S. pyogenes strains and the E. coli clones. The serotypes

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

67

of the strains containing the deletion were determined using the emm-genotyping
method, which compares sequences of a portion of the gene encoding the M
protein.
The results of the emm-genotyping were interesting, since all seven
strains containing the deleted hylA proved to be M-type 3. The deletion occurred
in the same location in each strain. Earlier experiments in this lab gave a
positive result for the enzyme assays on some of these deleted strains (70). The
current study showed similar results, with small zones of clearing on enzyme
assay plates. But it was determined that those results were actually due to the
action of the hyaluronate lyase produced by streptococcal bacteriophage. A
comparison of enzyme activity assays of the S. pyogenes strains to the hylA
genes from the same strains cloned into E. coli reveals that a slightly positive
assay in S. pyogenes becomes negative when the gene is cloned and expressed
in E. coli. In addition, there is a marked difference in enzymatic activity between
the bacteriophage enzyme and the chromosomal enzyme (Fig. 5).
These first 16 strains of S. pyogenes were then subjected to phylogenetic
analysis. A consensus tree was constructed based on the nucleotide sequence
of the hylA genes beginning at the 5’ start codon (GTG) and ending at base pair
2,272, the region not encompassing the 183 base pair deletion. The resulting
tree (Fig. 13) grouped the M-3 hylA sequences as a separate clade from the M22 and M-4 sequences. Additionally, the hylA sequences from three M-types
representing the truncated form of hylA (M-1, M-5 and M-18) also grouped into a
separate clade. These data suggested that there may be a correlation between

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

68

the hylA gene structure and the S. pyogenes serotype which is based on a
different gene product, the M protein. If this could be proven, then there is the
possibility that the structure of the hylA gene has an impact on the pathogenic
characteristics of infection by S. pyogenes.
On the basis of these initial results, we examined a total of 32 S.
pyogenes strains which had been previously screened by PCR (70) and
determined to have the 3’ deletion. These strains were of unknown serotype; the
first set of experiments was to identify the serotype using the emm-genotyping
method. First, the strains were analyzed using restriction-length fragment
polymorphism (RFLP) of the emm gene so as to group similar types. The RFLP
analysis (Fig. 11) indicated similarities in banding patterns for some of the
digested emm genes.

In the enzyme assays (Table 2) the only strains that

tested positive for enzymatic activity were M-types 4 and 22. As was mentioned,
this result does not agree with previous work, which found other M-types positive
for enzymatic activity (70). However, strains studied in these experiments that
had been previously identified as enzyme-positive and which were not M-type 4
or 22 were determined to produce bacteriophage hyaluronate lyase, accounting
for the difference in results. As for the emm-genotyping results, one-half of the
deleted strains examined were M-type 3, while the remainder were from a variety
of M-types but did not include M-types 4 or 22 (Table 3). These data was
compared with the RFLP results; similar banding patterns on those gels were
shown to be correlated with serotype.
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Additional phylogenetic analysis was performed on the hypervariable
region of the emm gene sequences, the same region used to differentiate
serotype in the emm-genotyping method. The consensus tree which resulted
was divided into clades much like the consensus tree of the hylA gene
sequences. The sequences from M-types 4 and 22 grouped into a separate
clade from the sequences of the M-1, M-3 and other enzyme-negative serotypes.
Thus, there appears to be relatedness, in a phylogenetic sense, between the
emm genes and the hylA genes of different serotypes of S. pyogenes.

Fragment cloning studies. S. pyogenes 635-02 is a hyaluronate lyase
positive M-4 strain. This strain was used in a series of experiments designed to
further explore the structure of the hylA gene and ascertain which portion(s) of
the protein might play a role in enzymatic activity. This gene was amplified in
four different forms and the fragments cloned into the pCRT7-NT expression
vector in order to assess the importance of different gene regions: the entire hylA
gene, the hylA gene fragment from the start codon to the start of the deletion
region at base pair 2,273, the hylA gene fragment from the start codon to the
premature stop codon found in the truncated form and finally, the hylA gene
fragment from the codon immediately downstream from the putative signal
peptide cleavage site found at the 5’ end of the gene (Fig. 8). The complete
gene was positive for enzyme activity as was the fragment lacking the signal
peptide. A fragment of hylA from the start codon to the start of the deletion
region was negative for enzymatic activity. But surprisingly, the fragment of hylA
from the start codon to the premature stop codon was positive for enzymatic
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activity, unlike a similarly amplified hylA gene from the M-1 strain SF 370 (Hynes,
personal communication), which had no enzymatic activity when cloned and
expressed in E. coli.
These results would seem to indicate two things. First, because the wildtype M-1 gene is enzymatically inactive while the prematurely truncated M-4
strain is active, the difference in phenotype is caused by differences in the genes
themselves. Because the gene fragments were cloned into E. coli and were
under the influence of the plasmid-derived promoter, this would eliminate the
influence of either an upstream promoter region or the interaction of a promoter
with a regulatory protein as a cause of the difference in phenotype between non
active and active hylA enzyme in S. pyogenes.
Secondly, the region somewhere between the start of the deletion region
and the start of the truncation’s premature stop codon is important somehow to
the enzymatic function of the HylA protein. Alignments of the amino acid
sequences from this region in an M-4 hylA and an M-1 hylA reveal three amino
acid changes. One of these changes, from a lysine residue in the M-4 to an
arginine residue in the M-1, would not result in a change in property of the amino
acid, as both are polar and hydrophilic. But the other two changes could have
consequences on the property of the amino acid. At one location, a threonine in
the M-4 changes to a methionine in the M-1, and at the other site, a glutamate
changes to a glycine. Both of these changes result in a change from an amino
acid residue that is polar and hydrophilic in the M-4 hy\A sequence to an amino
acid that is non-polar and hydrophobic in the M-1 hylA sequence. Changes such
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as this may result in an alteration in either the tertiary structure of the enzyme or
in its ability to bind or interact with other ions or elements in its environment. Both
of these characteristics have the potential to change the function of the hylA
enzyme, and at least in terms of the truncated and full-length structures could
explain why an M-type 4 or 22 is active while a prematurely truncated hylA is not.
The fact that these amino acid residues are missing in the M-type 3 and other
deleted strains could explain their lack of activity because these amino acids are
located within the deleted region. Protein modeling of the hylA gene may reveal
interactions between regions of the gene that are only discernable from the
tertiary, folded structure of the protein, and some of these interactions could
involve the regions studied here.

Site-directed mutagenesis studies. The region of the hylA gene
addressed in the site-directed mutagenesis studies is located in an entirely
different domain of the protein than discussed above. While the structure of HylA
from S. pyogenes has not been as well-characterized as the lyase from either S.
agalactiae or S. pneumoniae, both of which have been crystallized, the high
degree of similarity in sequence suggests similarity in structure is likely. Both the
S. pneumoniae hyaluronate lyase (SpnHL) and the S. agalactiae lyase (SagHL)
are composed of four domains: an N-terminal domain, a spacer domain, an adomain and a C-terminal domain (1). The region comprising the deletion and
truncation in HylA is located in the C-terminal domain of the other lyases. The
amino acid residue studied in the site-directed mutagenesis experiments is
located in a conserved region in the N-terminal domain of the enzyme.
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This amino acid, located at position 199 of HylA, is an aspartic acid
residue in both the M-4 and M-22 serotypes, both of which are enzymatically
active. Likewise, an aspartic acid residue is found at an analogous position in S.
suis, S. pneumoniae, S. agalactiae and Staphylococcus aureus, all of which
produce an enzymatically active hyaluronate lyase. Yet the amino acid at
position 199 in the HylA of all enzyme-negative serotypes determined from
published sequences, as well as those serotypes which were sequenced in this
project, is valine. Because this difference involves only one amino acid in an
otherwise highly-conserved region and because this region is found within the
substrate-binding cleft or catalytic domain identified in the SpnHL and SagHL
crystal structures, it was important to determine whether it played a role in the
enzyme’s activity.
When the hylA gene from the S. pyogenes strain 1055, an M-3 serotype
with the deletion structure, was mutated to cause a change in the translated
protein from valine to aspartic acid at position 199, enzymatic function was not
restored. But when the same mutation was performed on the M-1 strain SF370,
enzymatic activity was restored to the resulting protein (Hynes, personal
communication). When the reverse mutation was performed on the
enzymatically active M-22 strain 10403, resulting in a change from aspartic acid
to valine, activity was lost. So it was not possible to restore enzymatic activity to
the form of hylA lacking the the deletion region. But it is possible to restore
activity to the truncated form that does contain this region, or to eliminate that
activity in the full-length gene form. Taken together, these results provide
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additional evidence of the importance of this region to the enzymatic activity of
HylA. Further, these results agree with the findings of the hylA fragment cloning
experiments discussed earlier, which indicated as well that the deleted region is
important to enzymatic activity. If it was not, conversion of amino acid at position
199 from valine to aspartic acid would have restored enzyme function.
But why would regions in two separate domains of the HylA protein
determine whether it was enzymatically active or not? And what, if any,
interaction between the N-terminal domain and the C-terminal domain occurs
that could also influence the enzyme’s properties? Studies of the S. pneumoniae
lyase, SpnHL, demonstrated that the N- and C-terminal regions folded and
unfolded independently of one another. Further, the N-terminal domain was
capable of carrying out the enzymatic reaction on its own, after having been
separated from the C-terminal domain (2). Indeed, the catalytic site, where
substrate binding and degradation occurs, is located in the N-terminal domain
(3). This would seem to indicate that the N-terminal domain is more necessary, a
finding consistent with the site directed mutagenesis experiment conducted on
the amino acid located at position 199 of HylA.
Both regions are possibly essential for HylA to degrade its substrate. The
S. agalactiae lyase, SagHL, binds and degrades substrate at the a-domain
located in the N-terminus. But independent of the C-terminus, it has only about
10% of the activity that the enzyme displays when it is left in its entirety. It has
been proposed that calcium ions act to modulate the conformation of the
hyaluronic acid substrate, making it more suitable for catalysis (3), and while no
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binding sites for calcium have been observed on the SagHL enzyme, studies
have shown the enzymatic activity to be Ca++-dependent (55). Were this the
case for the S. pyogenes HylA, it could explain why the change from a glutamate
residue in the M-4 HylA to a glycine residue in the M-1 HylA results in a form of
the enzyme that is not enzymatically active, since glutamate is known to bind
calcium. However, when the HylA from an M-1 strain of S. pyogenes was
changed at position 199, enzymatic activity was restored. Since the amino acids
in the M-1 are presumably not able to bind calcium, this result indicates that
those residues are not as important as proposed. But because the M-3
mutagenesis did not restore activity, this indicates that the region from the
deletion to the termination site is important, not necessarily the particular amino
acids. The role of this region therefore remains unclear.

The bacteriophage hyaluronate lyase in S. pyogenes. The contribution
of bacteriophage to the virulence of S. pyogenes and other pathogenic bacteria is
significant. And while the hyaluronate lyase produced by bacteriophage has not
been shown to play a role in the disease process, it does allow the virus to gain
access into the bacterial cell receptors through the hyaluronic acid capsule. After
infection, and potential integration into the bacterial chromosome some
bacteriophage-encoded enzymes and toxins can be expressed by the
Streptococcus. The fact that the bacteriophage hyaluronate lyase has the same
substrate as the chromosomal enzyme encoded by hylA is quite interesting.
Even though the two lyases share no similarity at the nucleotide or amino acid
level, their identical enzymatic function raises the question of whether there is a
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correlation between the presence of bacteriophage lyase and the gene structure
of hylA. If it could be shown that serotypes without an active form of the enzyme
were more likely to contain the hyIP and hylP2 genes for the bacteriophage
enzyme than the serotypes with the active enzyme form, then the argument
could be made that having the phage enzyme reduced the selective pressure for
the bacterium to maintain a functional form of the chromosomal enzyme.
Therefore mutations, deletions and truncations of hylA, would be tolerated, in an
evolutionary sense because the bacterium would still possess a functional
enzyme.
The results of the present studies, however, dispel such a notion of a
connection between hylA gene form and the presence or absence of the phage
genes. The presence of hyIP and hylP2 was universal among the strains of S.
pyogenes surveyed, regardless of serotype. When existing as a prophage the
phage hyaluronidase is unlikely to be expressed. Upon induction, expression of
phage proteins, including hyaluronidase would occur. This would then result in
formation of phage particles and potentially release of phage hyaluronidase
(either free or attached to the phage tail) into the extracellular milieu, detected as
a zone of clearing in our assay plates.

The role of mga, covR and other potential regulators in hylA
expression. Because the regulatory mechanism for hylA expression has yet to
be elucidated, some known regulatory proteins were scrutinized as potential
regulators of the gene. The Mga protein activates or represses expression of
numerous cell-associated and secreted virulence factors elaborated by S.
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pyogenes, and was the first such regulator to be studied extensively. A mutant
strain of an enzyme-positive M-4 S. pyogenes containing an inactivated mga
gene was used to determine whether mga controls the expression olhylA. The
results of an enzymatic assay of the wild-type, parental strain and the mutant
strain showed no difference in activity, indicating no involvement of Mga in hylA
expression. These results led to a search for other potenial regulators’ effects on
the gene.
The CovR protein is the response regulator portion of a two-component
regulatory system in S. pyogenes that influences up to 15% of the virulence
factors contained in its genome (26). This magnitude of influence, coupled with
the fact that CovR regulates expression of the genes responsible for the
hyaluronic acid capsule, made it a likely candidate for the role of hylA regulator.
Additionally, it would make sense that a two-component regulator system would
be responsible for the expression of hylA, since these types of regulators act by
conveying a signal from the extracellular environment to the bacterial
chromosome. This characteristic of the enzyme’s expression may indicate that
such expression is a result of an as yet unknown external stimulus, and the two
component type of regulator system’s design allows the cell to react to and
communicate external signals to its chromosome.
The results of the studies in which the cot/R gene was inactivated in the
enzyme-positive strain 635-02 indicated that covR does not play such a role in
the regulation of hylA expression. Similar experiments were also conducted in
which two other known two-component response regulator proteins, namely
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(Spt9 and Spt12), were inactivated in the same strain. These both produced the
same results; expression of hylA was neither decreased nor increased in the
mutant strains containing inactivated response regulators.
There are 8 other putative response regulator proteins which have been
inserted into the same plasmid construct used in the covR studies. Initial
attempts to electroporate these constructs into S. pyogenes strain 635-02 failed.
This isn’t surprising, given that the M-22 and M-4 strains of S. pyogenes have
historically been difficult to use in electroporation experiments (Mclver personal
communication). But further study is warranted, as is the study of any of the
characterized and putative regulator proteins thus far identified in S. pyogenes.
And finally, a more general approach could be undertaken in order to identify the
regulator of hylA expression. Transposon mutagenesis experiments could be
performed in which the random insertion of transposable elements into the
genome of an enzyme-positive strain of S. pyogenes could be used to locate the
protein or proteins associated with the expression of hylA.
Based on current results and the fact that no increase or decrease in
expression of hylA in genome-wide studies has been reported, the protein or
proteins which are responsible for expression of hylA remains a mystery.
Regulation of the expression of virulence factors in S. pyogenes involves an
enormously complex network system that is sometimes redundant and
overlapping, making its ultimate characterization difficult. While the nature of the
environmental signal that triggers hylA expression has yet to be determined, it
has been shown that its expression follows a specific pattern, with levels rising
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and falling at particular time points after inoculation of a culture into fresh media.
In fact, there is a bimodal pattern to this expression, perhaps indicating more
than one external stimulus (70). There are other proteins that have the potential
of being regulators of hylA, some of which have been characterized and some
which have been putatively identified in genomic searches. One such protein is
Srv. The expression of srv has been studied, and intriguingly, its expression
mimics that of hylA in enzyme-positive strains of S. pyogenes; the graph of
expression over time exhibits the same bimodal peaks at approximately the
same time points. Based on this apparent connection, a mutagenic plasmid
containing the srv gene fragment was obtained and attempts were made to
electroporate the construct into the chromosome of the M-4 strain 635-02 of S.
pyogenes. All attempts were unsuccessful, however. But it is possible that with
additional studies, another mutagenic plasmid containing the srv gene fragment
could be constructed, allowing the effect of inactivation of srv on hylA expression
to be ascertained.

The role of hylA In S. pyogenes. All of the efforts described above were
undertaken with the assumption that the hylA gene of S. pyogenes exists to
encode a virulence factor used by the bacterium in the infection of its human
host. While hylA is not always mentioned in the literature, whenever a list of S.
pyogenes virulence factors is given, the enzyme is usually described as either a
virulence or spreading factor. Both the epidemiological and the regulatory
experiments of this project were designed with the underlying assumption that
hylA’s role is one of virulence in S. pyogenes. But rather than clarify that role as
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such, the results of both sets of experiments have left more questions
unanswered than answered, and in fact, have raised the question of whether
HylA has another role entirely.
The epidemiology and gene structure studies were consistent with the
premise that the structure of the hylA gene is directly related to the function of the
enzyme, hyaluronate lyase, that it encodes. A hylA gene having a 183 bp, in
frame deletion in its 3’ region will not encode a functional enzyme. And neither
does a hylA gene containing a premature stop codon in the 3’ region. But
whether it is this C-terminus region or the N-terminus location of the aspartic acid
to valine change that is responsible for the enzyme activity phenotype is still
unknown. The possibility exists that some interaction between the two domains
plays a role in the enzyme’s function. More study is necessary to clarify the role
both domains play in the enzyme’s function, but it is clear that both are somehow
important.
The results of the emm-genotyping experiments are some of the most
intriguing of this project. The M-1 serotype has been the most common cause of
invasive disease and is most often associated with epidemics (7). The M-3
serotype is also linked to severe invasive disease and has been associated with
streptococcal toxic shock syndrome. The link of M18 serotypes to outbreaks of
ARF has been repeatedly established (8). These serotypes, accepted as being
among the most virulent forms of S. pyogenes, have non-functional HylA
proteins, with the loss of activity, as shown by this project, due to a deletion or to
an amino acid change. The only evidence of the correlation of a functional hylA
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genotype, that of the M-22 serotype, with disease pattern, is a study which found
that M-type 22 isolates were the most prevalent serotype found in self-limiting
pharyngeal infections worldwide. Further, in numerous epidemiological studies
that related M-serotype to more severe or invasive manifestations of infection
with S. pyogenes, the numbers of M-type 4 or 22 serotypes involved is low (17,
20, 22, 43, 60, 61) .
Taken as a whole, these results would almost point to a role for a
functional hyaluronate lyase as an “anti-virulence” factor. In fact, they could
solve the riddle of why the bacterium produces an enzyme capable of degrading
one of its primary defense mechanisms. The hyaluronic acid capsule is highly
resistant to phagocytosis by host immune cells. Its degradation would eliminate
this cloak of protection, allowing the host immune response to clear the infection
before the bacterium could move into deeper tissues and set the stage for the
more invasive forms of disease. If the mutant, non-functional forms of the
enzyme, such as those found in the M-3, M-1, M-18 and other virulent serotypes,
failed to degrade the capsule, the bacterium could have evolved the capability to
cause the more invasive and life-threatening diseases. Failure to degrade the
capsule could allow the bacterium to evade the host immune defenses,
particularly phagocytosis, for a longer period of time, invade more deeply into the
host tissue and exploit another niche. The original purpose of the enzyme may
have been a role in nutrition, as has been suggested (66), but the evolution of the
more virulent M-types with the enzyme-negative phenotype resulted in serotypes
of S. pyogenes that took on an entirely new and more dangerous form. Both
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forms of the bacterium continue to exist; the mild and self-limiting and the more
invasive form. Both are successful at exploiting unique niches within the human
host tissue.
The regulation studies failed to identify the protein or proteins responsible
for the expression of hylA in S. pyogenes. Given the assumption that the gene
does encode a virulence factor, the proteins investigated in the mutagenesis
studies were likely candidates for this role. But in light of the conclusion that hylA
was not originally intended to encode a virulence factor but rather a type of
housekeeping or nutritional protein, it could be that these studies looked at the
wrong regulatory systems. Future studies should examine other types of
regulatory genes and networks that control cellular processes other than
virulence.
Ultimately, regardless of what role is determined for HylA in S. pyogenes,
the enzyme, the gene that encodes it and the regulatory mechanism that controls
its expression are more important than the amount of research conducted on it
would seem to indicate. The stark difference in virulence phenotype between the
enzyme-positive serotypes and the enzyme-negative serotypes alone points to a
larger role for the enzyme than has been previously assigned. Further
elucidation of this role, along with the clarification of the process that regulates
expression of hylA, will contribute greatly to the understanding of the bacterium
and its remarkable ability to persist and infect. This knowledge will hopefully
provide the tools with which to control one of the most successful pathogens to
infect humans.
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CONCLUSIONS

The experiments conducted in this project were designed to relate the
structure of the hylA gene of Streptococcus pyogenes to its function as an
enzyme, and further, to relate this structure and function to the characteristics of
diverse infections caused by S. pyogenes. The diseases caused by S. pyogenes
take many forms that range in severity from mild to life-threatening, and the
myriad of virulence factors it expresses play a major role in its success. The
100- plus serotypes of the bacterium display different expression profiles of these
virulence factors, and it is important to understand how this differential
expression affects the characteristics of its pathogenesis.
This study characterized the differences in the hylA enzyme between the
functional and non-functional phenotype. Differences in amino acids at two
locations were both shown to affect activity. The 3’ region in the C-terminus
contains a 183 base pair deletion or a premature stop codon and both result in a
loss of enzymatic activity. And a region in the N-terminus contains a one- amino
acid change in an otherwise conserved region that also results in a loss of
enzymatic activity. The exact nature of the relationship of these regions to
enzymatic activity and the possibility that their interaction is important to activity
were not determined by this research but future investigation may completely
elucidate the structure/function of the hylA gene.
The consistency of the association between enzyme phenotype and the
nature of infection caused by S. pyogenes suggests that a correlation does exist.
M-types 4 and 22 have a functional enzyme capable of degrading the anti
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phagocytic hyaluronic acid capsule, and are rarely associated with the more
severe and invasive forms of infection. In contrast, the M-types 1, 3, 18, and
others that express a non-functional enzyme, are repeatedly associated with,
necrotizing fasciitis, streptococcal toxic shock syndrome, and acute rheumatic
fever the more invasive and life-threatening S. pyogenes infections.
It remains to be shown that the protein encoded by hylA originally
functioned in a non-virulent, nutritional role and a mutation of the gene creating
an inactive enzyme resulted in a new and more virulent phenotype of S.
pyogenes. But the evidence shown here, coupled with the fact that none of the
most likely regulators of virulence in S. pyogenes appears to control the
expression of hylA, lend credence to this idea.
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APPENDIX A

Media, materials, antibiotics and equipment
Media, materials and equipment used in this project are listed under
manufacturer.
A. Fisher Scientific, Pittsburgh, PA.
1. Luria Bertone powdered media
2. Yeast Extract
3. Sodium Chloride, Enzyme Grade
4. Agar, Granulated Solidifying Agent
5. Agarose Low EEO, Electrophoresis Grade
6. Ethidium Bromide, Electrophoresis Grade
7. Tris HCI, Molecular Biology Grade
8. EDTA, Disodium Salt, Electrophoresis Grade
9. Boric Acid, Electrophoresis Grade
10.

Sodium Hydroxide, Molecular Biology Grade

11.

Reagent Anhydrous Ethyl Alcohol

12.

Sucrose, Anhydrous, Molecular Biology Grade

13.

Bovine Serum Albumin, Biotechnology Grade

14.

Paraffin Oil, Light

15.

Glacial Acetic Acid, Molecular Biology Grade

16.

Glycerol, Molecular Biology Grade

17.

100 X 15 mm Sterile Petri Dishes
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B.

Sigma, St. Louis. MO.
18. Hyaluronic Acid (from human umbilical cord)
19. Erythromycin
20.Ampicillin
21.Spectinomycin
22. Streptomycin
23. Tetracycline hydrochloride
24. Mutanolysin
25. Egg White Lysozyme

B. Promega. Madison. Wl.
1. Wizard Plus SV Miniprep Plasmid Purification Kit
2. Wizard PCR Preps DNA Purification System
3. Taq DNA Polymerase in Storage Buffer B
4. 10X PCR Buffer
C. Invitrogen, Carlsbad. CA.
1. pCRT7-NT Cloning Vector
2. Top 10 Chemically Competent E. coli Cells
3. Platinum PCR Supermix
D. BD. Franklin Lakes. NJ.
1. Brain Heart Infusion, Powdered
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APPENDIX B

GenBank Accession Numbers for hylA Gene Sequences

hylA Gene From Strain

Accession Number

6219
4786
3200
437
4283
4282
2397
445
1020
1055
350
3779
422
872
94146

EU078688
EU078695
EU078689
EU078696
EU078690
EU078697
EU078700
EU078691
EU078701
EU078692
EU078693
EU078702
EU078694
EU078698
EU078699
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APPENDIX C
Strains of S. pyogenes used in study
Strain

M-Type

Hyaluronate Lyase Activity

WF 006
WF 019
WF 045
WF 048
WF 053
WF 059
WF 061
WF 087
WF 097
WF 110
WF 169
WF 171
WF 184
WF 007
WF 041
WF 066
WF 081
WF 099
WF 172
WF 005
WF 012
WF 037
WF 047
WF 051
WF 055
WF 067
WF 073
WF 076
WF 082
WF 105
WF 125
WF 159
ODU 114
ODU 350
ODU 380
ODU 422
ODU 869A
ODU 869B
ODU 871
ODU 872
ODU 880

1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3

Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
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Strain

M-Type

Hyaluronate Lyase Activity

ODU 1020
ODU 1045
ODU 1055
ODU 1074
ODU 94146
ODU 95-4383
ODU CGH 97-1
WF 002
WF 060
WF 065
WF 093
WF 100
WF 117
WF 124
WF 152
WF 180
ODU 445
ODU 2397
ODU 4282
ODU 4283
ODU 635-02
WF 039
WF 057
WF 085
WF 108
ODU 364
ODU 600
WF 011
WF 098
WF 142
WF 148
WF 157
WF 162
WF 166
WF 168
WF 179
ODU 92
WF 014
WF 025
WF 064
WF 070
WF 078
WF 112
WF 003
WF 021

3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
6
6
6
6
6
6
6
6
6
9
11
11
11
11
11
11
12
12

Negative
Negative
Negative
Negative
Negative
Negative
Negative
Posit ve
Posit ve
Posit ve
Posit ve
Posit ve
Posit ve
Posit ve
Posit ve
Posit ve
Posit ve
Posit ve
Posit ve
Posit ve
Posit ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
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Strain

M-Type

Hyaluronate Lyase Activity

WF 026
WF 033
WF 035
WF 052
WF 054
WF 063
WF 089
WF 094
WF 101
WF 126
WF 132
WF 140
WF 144
WF 150
WF 155
WF 156
WF 178
WF 186
WF 187
ODU 440
ODU 462
ODU 777
WF 016
ODU 1013
WF 009
WF 151
WF 170
ODU 437
ODU 4786
ODU 3200
ODU 6219
ODU 10403
WF 022
WF 050
WF 056
WF 058
WF 077
WF 084
WF 113
WF 164
ODU 788
WF 017
ODU 703
WF 020
WF 167

12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
17
17
18
18
22
22
22
22
22
22
22
22
28
28
28
28
28
28
28
28
32
41
43
44
44

Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
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Strain

M-Type

Flyaluronate Lyase Activity

WF 192
WF 008
WF 010
WF 043
WF 090
WF 092
WF 095
WF 103
WF 109
WF 114
WF 135
WF 173
WF 174
WF 176
WF 177
WF 189
WF 193
WF 175
WF 194
WF 195
WF 036
WF 111
WF 143
WF 147
WF 015
WF 044
WF 086
WF 107
WF 115
WF 122
WF 123
WF 127
WF 128
WF 130
WF 136
WF 141
WF 153
WF 165
WF 181
WF 182
WF 188
ODU 58
WF 083
WF 091
WF 068

49
58
58
58
58
58
58
58
58
58
58
58
58
58
58
58
58
68
68
68
73
73
73
73
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
77
77
78

Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
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Strain

M-Type

Flyaluronate Lyase Activity

ODU 7
WF 088
WF 074
WF 096
WF 080
WF 131
WF 139
WF 154
WF 004
WF 062
WF 071
WF 075
WF 129
WF 161
WF 001
WF 183
WF 034
WF 049
WF 102
WF 137
WF 013
WF 163
WF 185
WF 104
WF 106
WF 116
WF 121
WF 145
WF 160
WF 072
WF 119
WF 134
WF 138
WF 069
WF 190
WF 120
WF 191
ODU 795
ODU 389
ODU 944
ODU 561
ODU 250
WF 018
WF 023
WF 024

78
82
83
84
85
87
87
87
89
89
89
89
89
89
92
92
94
94
94
94
96
96
96
114
114
114
114
114
114
118
119
st1815
st1815
st5282
stc36
stg480
stg485
st3765
stg5420
stc839
stg166B
stck401
untyped
untyped
untyped

Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Negat ve
Positive
Positive
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
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Strain

M-Type

Hyaluronate Lyase Activity

WF
WF
WF
WF
WF
WF
WF
WF
WF
WF
WF
WF
WF
WF
WF
WF

untyped
untyped
untyped
untyped
untyped
untyped
untyped
untyped
untyped
untyped
untyped
untyped
untyped
untyped
untyped
untyped

Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Positive
Negative
Negative
Positive
Negative
Negative
Negative
Negative

027
028
029
030
031
032
038
040
042
046
079
118
133
146
149
158
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